Document:

Exhibit
10.9

 

SECURITIES
PURCHASE AGREEMENT

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 13, 2017, by and between PositiveID
Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the
“Company”), and UNION CAPITAL, LLC, a New York limited liability company, with its address at 525 Norton Parkway,
New Haven, CT 06511 (the “Buyer”).

 

WHEREAS:

 

A. The
Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the Securities Act of 1933, as amended (the “1933 Act”);

 

B. Buyer
desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement two 12%
convertible notes of the Company, in the forms attached hereto as Exhibit A and B in the aggregate principal amount of $104,000.00
(with the first note being in the amount of $52,000.00 and the second note being in the amount of $52,000.00) (together with any
note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms
thereof, the “Note”), convertible into shares of common stock, of the Company (the “Common Stock”), upon
the terms and subject to the limitations and conditions set forth in such Note. Each of the two notes shall contain a 4% OID such
that the purchase price of each note shall be $50,000. The first of the two notes (the “First Note”) shall be paid
for by the Buyer as set forth herein. The second note (the “Second Note”) shall initially be paid for by the issuance
of an offsetting $50,000.00 secured note issued to the Company by the Buyer (“Buyer Note”), provided that prior to
conversion of the Second Note, the Buyer must have paid off the Buyer Note in cash such that the Second Note may not be converted
until it has been paid for in cash by Buyer.

 

C. The
Buyer wishes to purchase, upon the terms and conditions stated in this Agreement, such principal amount of Note as is set forth
immediately below its name on the signature pages hereto; and

 

NOW
THEREFORE, the Company and the Buyer severally (and not jointly) hereby agree as follows:

 

1. Purchase
and Sale of Note.

 

a. Purchase
of Note. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase
from the Company such principal amount of Note as is set forth immediately below the Buyer’s name on the signature pages
hereto.

_____

Company
Initials

 

    	 

     

    

 

b. Form
of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Note to be issued and
sold to it at the Closing (as defined below) (the “Purchase Price”) by wire transfer of immediately available funds
to the Company, in accordance with the Company’s written wiring instructions, against delivery of the Note in the principal
amount equal to the Purchase Price as is set forth immediately below the Buyer’s name on the signature pages hereto, and
(ii) the Company shall deliver such duly executed Note on behalf of the Company, to the Buyer, against delivery of such Purchase
Price.

 

c. Closing
Date. The date and time of the first issuance and sale of the Note pursuant to this Agreement (the “Closing Date”)
shall be on or about November 13, 2017, or such other mutually agreed upon time. The closing of the transactions contemplated
by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed to by the parties.
Subsequent Closings shall occur when the Buyer Note is repaid.

 

2. Buyer’s
Representations and Warranties. The Buyer represents and warrants to the Company that:

 

a. Investment
Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion of
or otherwise pursuant to the Note, such shares of Common Stock being collectively referred to herein as the “Conversion
Shares” and, collectively with the Note, the “Securities”) for its own account and not with a present view towards
the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act;
provided, however, that by making the representations herein, the Buyer does not agree to hold any of the Securities
for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant
to a registration statement or an exemption under the 1933 Act.

 

b. Accredited
Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D
(an “Accredited Investor”). Any of Buyer’s transferees, assignees, or purchasers must be “accredited investors”
in order to qualify as prospective transferees, permitted assignees in the case of Buyer’s or Holder’s transfer, assignment
or sale of the Note.

 

c. Reliance
on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of
the Buyer to acquire the Securities.

 

d. Information.
The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with
all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of
the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for
so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company. Notwithstanding
the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information
unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries
nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or
affect Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. The Buyer
understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that
may constitute a breach of any of the Company’s representations and warranties made herein.

 

    	2

     

    

 

e. Governmental
Review. The Buyer understands that no United States federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the Securities.

 

f. Transfer
or Re-sale. The Buyer understands that (i) the sale or re-sale of the Securities has not been and is not being registered
under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (a) the Securities
are sold pursuant to an effective registration statement under the 1933 Act, (b) in the case of subparagraphs (c), (d) and (e)
below, the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be in form, substance
and scope customary for opinions of counsel in comparable transactions to the effect that the Securities to be sold or transferred
may be sold, or transferred pursuant to an exemption from such registration, including the removal of any restrictive legend which
opinion shall be accepted by the Company, (c) the Securities are sold or transferred to an “affiliate” (as defined
in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”) of the Buyer who agrees to sell or otherwise
transfer the Securities only in accordance with this Section 2(f) and who is an Accredited Investor, (d) the Securities are sold
pursuant to Rule 144, or (e) the Securities are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation
S”); (ii) any sale of such Securities made in reliance on Rule 144 may be made only in accordance with the terms of said
Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances in which the seller (or the
person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require
compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and (iii) neither
the Company nor any other person is under any obligation to register such Securities under the 1933 Act or any state securities
laws or to comply with the terms and conditions of any exemption thereunder (in each case). Notwithstanding the foregoing or anything
else contained herein to the contrary, the Securities may be pledged as collateral in connection with a bona fide margin
account or other lending arrangement.

 

g. Legends.
The Buyer understands that the Note and, until such time as the Conversion Shares have been registered under the 1933 Act will
be sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as of a particular date that
can then be immediately sold, the Conversion Shares may bear a restrictive legend in substantially the following form (and a stop-transfer
order may be placed against transfer of the certificates for such Securities):

 

    	3

     

    

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security
upon which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for
sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or Regulation
S without any restriction as to the number of securities as of a particular date that can then be immediately sold, and (b) such
holder provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act,
and that legend removal is appropriate, which opinion shall be accepted by the Company so that the sale or transfer is effected.
The Buyer agrees to sell all Securities, including those represented by a certificate(s) from which the legend has been removed,
in compliance with applicable prospectus delivery requirements, if any. In the event that the Company does not accept the opinion
of counsel provided by the Buyer with respect to the transfer of Securities pursuant to an exemption from registration, such as
Rule 144 or Regulation S, within 2 business days, it will be considered an Event of Default under the Note.

 

h. Authorization;
Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf
of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.

 

i. Residency.
The Buyer is a resident of the jurisdiction set forth immediately below the Buyer’s name on the signature pages hereto.

 

j.
No Short Sales. Buyer/Holder, its successors and assigns, agree that so long as the Note remains outstanding, the Buyer/Holder
shall not enter into or effect “short sales” of the Common Stock or hedging transaction which establishes a short
position with respect to the Common Stock of the Company. The Company acknowledges and agrees that upon delivery of a Conversion
Notice by the Buyer/Holder, the Buyer/Holder immediately owns the shares of Common Stock described in the Conversion Notice and
any sale of those shares issuable under such Conversion Notice would not be considered short sales.

 

    	4

     

    

 

3. Representations
and Warranties of the Company. The Company represents and warrants to the Buyer that:

 

a. Organization
and Qualification. The Company and each of its subsidiaries, if any, is a corporation duly organized, validly existing and
in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and
other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted.

 

b. Authorization;
Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the
Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms
hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the
transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance and reservation
for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized by the Company’s
Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its shareholders is required,
(iii) this Agreement has been duly executed and delivered by the Company by its authorized representative, and such authorized
representative is the true and official representative with authority to sign this Agreement and the other documents executed
in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery
by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms.

 

c. Issuance
of Shares. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance
with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances
with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the
Company and will not impose personal liability upon the holder thereof.

 

d. Acknowledgment
of Dilution. The Company understands and acknowledges the potentially dilutive effect to the Common Stock upon the issuance
of the Conversion Shares upon conversion of the Note. The Company further acknowledges that its obligation to issue Conversion
Shares upon conversion of the Note in accordance with this Agreement, the Note is absolute and unconditional regardless of the
dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

    	5

     

    

 

e. No
Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance
of the Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation
or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event
which with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any of
its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the Company or
its securities are subject) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company
or any of its Subsidiaries is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect). All consents, authorizations,
orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been obtained
or effected on or prior to the date hereof. The Company is not in violation of the listing requirements of the OTC Markets Exchange
(the “OTC MARKETS”) and does not reasonably anticipate that the Common Stock will be delisted by the OTC MARKETS in
the foreseeable future, nor are the Company’s securities “chilled” by FINRA. The Company and its Subsidiaries
are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

f. Absence
of Litigation. Except as disclosed in the Company’s Periodic Report filings with the SEC, there is no action, suit,
claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization
or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or
any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect.
Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened
proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse
effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

g. Acknowledgment
Regarding Buyer’ Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely in the
capacity of arm’s length purchasers with respect to this Agreement and the transactions contemplated hereby. The Company
further acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to this Agreement and the transactions contemplated hereby and any statement made by the Buyer or any of its respective
representatives or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation
and is merely incidental to the Buyer’ purchase of the Securities. The Company further represents to the Buyer that the
Company’s decision to enter into this Agreement has been based solely on the independent evaluation of the Company and its
representatives.

 

    	6

     

    

 

h. No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would
require registration under the 1933 Act of the issuance of the Securities to the Buyer.

 

i. Title
to Property. The Company and its subsidiaries have good and marketable title in fee simple to all real property and good and
marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries,
in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 3(i) or such as would
not have a material adverse effect. Any real property and facilities held under lease by the Company and its subsidiaries are
held by them under valid, subsisting and enforceable leases with such exceptions as would not have a material adverse effect.

 

j. Bad
Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the
basis of being a “bad actor” as that term is established in the September 19, 2013 Small Entity Compliance Guide published
by the Securities and Exchange Commission.

 

k. Breach
of Representations and Warranties by the Company. If the Company breaches any of the representations or warranties set forth
in this Section 3, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered
an Event of default under the Note.

 

4. COVENANTS.

 

a. Expenses.
At the Closing, the Company shall reimburse Buyer for expenses incurred by them in connection with the negotiation, preparation,
execution, delivery and performance of this Agreement and the other agreements to be executed in connection herewith (“Documents”),
including, without limitation, reasonable attorneys’ and consultants’ fees and expenses, transfer agent fees, fees
for stock quotation services, fees relating to any amendments or modifications of the Documents or any consents or waivers of
provisions in the Documents, fees for the preparation of opinions of counsel, escrow fees, and costs of restructuring the transactions
contemplated by the Documents. When possible, the Company must pay these fees directly, otherwise the Company must make immediate
payment for reimbursement to the Buyer for all fees and expenses immediately upon written notice by the Buyer or the submission
of an invoice by the Buyer.

 

b. Listing.
The Company shall promptly secure the listing of the Conversion Shares upon each national securities exchange or automated quotation
system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance) and, so long as the
Buyer owns any of the Note Securities, shall maintain, so long as any other shares of Common Stock shall be so listed, such listing
of all Conversion Shares from time to time issuable upon conversion of the Note. The Company will obtain and, so long as the Buyer
owns any of the Securities, maintain the listing and trading of its Common Stock on the OTC MARKETS or any equivalent replacement
market, the Nasdaq stock market (“Nasdaq”), the New York Stock Exchange (“NYSE”), or the American Stock
Exchange (“AMEX”) and will comply in all respects with the Company’s reporting, filing and other obligations
under the bylaws or rules of the Financial Industry Regulatory Authority (“FINRA”) and such exchanges, as applicable.
The Company shall promptly provide to the Buyer copies of any notices it receives from the OTC MARKETS and any other markets on
which the Common Stock is then listed regarding the continued eligibility of the Common Stock for listing on such markets.

 

    	7

     

    

 

c. Corporate
Existence. So long as the Buyer beneficially owns the Note, the Company shall maintain its corporate existence and shall not
sell all or substantially all of the Company’s assets, except in the event of a merger or consolidation or sale of all or
substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i) assumes the Company’s
obligations hereunder and under the agreements and instruments entered into in connection herewith and (ii) is a publicly traded
corporation whose Common Stock is listed for trading on the OTC MARKETS, Nasdaq, NYSE or AMEX.

 

d. No
Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances
that would require registration of the Securities being offered or sold hereunder under the 1933 Act or cause the offering of
the Securities to be integrated with any other offering of securities by the Company for the purpose of any stockholder approval
provision applicable to the Company or its securities.

 

e. Breach
of Covenants. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies
available to the Buyer pursuant to this Agreement, it will be considered an event of default under the Note.

 

5. Governing
Law; Miscellaneous.

 

a. Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state courts of New York or in the federal courts located in the state and county
of New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted
hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The
Company and Buyer waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s
fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid
or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

    	8

     

    

 

b. Counterparts;
Signatures by Facsimile. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original
but all of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by
each party and delivered to the other party. This Agreement, once executed by a party, may be delivered to the other party hereto
by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

 

c. Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation
of, this Agreement.

 

d. Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

e. Entire
Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement
may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

f. Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, (iv) via electronic
mail or (v) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such
party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given
hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the
transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business
hours where such notice is to be received) or delivery via electronic mail, or the first business day following such delivery
(if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second
business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual
receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

 

    	9

     

    

 

If
to the Company, to:

PositiveID
Corp.

1690
South Congress Avenue

Suite
201

Delray
Beach, FL 33445

Attn:
William Caragol, CEO

 

If
to the Buyer:

UNION
CAPITAL, LLC

525
Norton Parkway,

New
Haven, CT 06511

Attn:
Yakov Borenstein, Manager

 

Each
party shall provide notice to the other party of any change in address.

 

g. Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any “qualified person”,
any “permitted assigns”, or “prospective transferee” that acquires or purchases Note Securities in a private
transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act, without the
consent of the Company with Buyer’s Opinion of Counsel. A qualified person is an “accredited investor” transferee,
assignee, or purchaser of the Note who succeeds to the Holder’s right, title and interest to all or a portion of the Note
accompanied with an Opinion of Counsel as provided for in Section 2(f).

 

h. Third
Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

i. Survival.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the
closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to
indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a
result of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set
forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they
are incurred.

 

j. Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

    	10

     

    

 

k. No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

l. Remedies.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for
a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach
by the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies
at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing
or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing
economic loss and without any bond or other security being required.

 

    	11

     

    

 

IN WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first
above written.

 

PositiveID
Corp.

 

	By:		 
	Name:	William
    Caragol	 
	Title:	CEO	 
	 	 	 
	UNION CAPITAL, LLC.	 
	 	 	 
	By:		 
	Name:  
    	Yakov
    Borenstein	 
	Title:
    	Manager	 

 

	AGGREGATE SUBSCRIPTION AMOUNT:	$104,000.00

 

Aggregate
Principal Amount of Notes:

 

Aggregate
Purchase Price:

 

Note
1: $52,000.00, less $2,000.00 in OID, less $2,500.00 in legal fees

 

Note
2: $52,000.00, less $2,000.00 in OID, less $2,500.00 in legal fees

 

    	12

     

    

 

EXHIBIT
A

144
NOTE - $52,000

 

    	13

     

    

 

EXHIBIT
B

BACK
END NOTE - $52,000

 

    	14Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

 

THIS SECURITIES PURCHASE
AGREEMENT (the “Agreement”), is entered into as of November 3, 2017 (the “Execution Date”),
by and among Probility Media Corporation, a Nevada corporation (the “Company”), and the investors listed on
the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

 

 

RECITALS

 

A.    
WHEREAS, the Company and each Buyer is executing and delivering this Agreement in reliance upon the exemption from securities
registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule
506(b) of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission
(the “SEC”) under the 1933 Act.

 

B.    
WHEREAS, the Company has authorized the issuance of a new series of promissory notes (the “Notes”), which
Notes shall be convertible into the Company’s common stock, par value $0.001 per share (the “Common Stock”),
in accordance with the terms of the Notes.

 

C.    
WHEREAS, each Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement,
(i) that principal amount of Notes set forth opposite such Buyer’s name in column (3) on the Schedule of Buyers (which
aggregate amount for all Buyers shall be $3,500,000), and (ii) Warrants, in substantially the form attached hereto as Exhibit
B (the “Warrants”), representing the right to acquire that number of shares of Common Stock set forth opposite
such Buyer’s name in column (4) on the Schedule of Buyers (which aggregate number for all Buyers shall be equal 3,888,886
Warrants). The shares of Common Stock issuable pursuant to the terms of the Notes are referred to herein as the “In-Kind
Payment Shares.” The shares of Common Stock issuable pursuant to the terms of the Warrants are referred to in this Agreement,
collectively, as the “Warrant Shares.”

 

D.    
WHEREAS, in order to induce the Buyers to enter into this Agreement, the Company has also agreed to issue those shares of
Common Stock to the Buyers as set forth opposite each such Buyer’s name in column (7) on the Schedule of Buyers (the
“Commitment Shares”).

 

E.     
WHEREAS, the Commitment Shares, the Notes, the Warrants, the In-Kind Payment Shares and the Warrant Shares are collectively
referred to herein as the “Securities”.

 

NOW, THEREFORE, in
consideration of the foregoing premises, and the promises and covenants herein contained, the receipt and sufficiency of which
are hereby acknowledged by the parties hereto, the Company and each Buyer (severally and not jointly), intending to be legally
bound, hereby agree as follows:

 

AGREEMENT

 

1.              
PURCHASE AND SALE OF NOTES AND WARRANTS.

 

(a)            
Closings.

 

(i)             
Notes, Warrants and Commitment Shares. Subject to the satisfaction (or waiver) of the
conditions set forth in Sections 6 and 7 below, the Company agrees to issue and sell to each Buyer, and each Buyer
severally, but not jointly, agrees to purchase from the Company at each Closing (as defined below), (x) the amount of Notes, as
is set forth opposite such Buyer’s name in column (3) on the Schedule of Buyers, and (y) Warrants to acquire up to
that number of Warrant Shares as is set forth opposite such Buyer’s name in column (4) on the Schedule of Buyers,
up to an aggregate amount of $3,500,000 for all Buyers In addition to the foregoing delivery of Notes and Warrants, the Company
also agrees to issue to each Buyer that amount of Commitment Shares to each Buyer as is set forth opposite such Buyer’s name
in column (7) on the Schedule of Buyers. 

 

(ii)           
Purchase Price. The aggregate purchase price for the Notes to be purchased by each
Buyer (the “Purchase Price”) shall be the amount set forth opposite such Buyer’s name in column (5) on
the Schedule of Buyers equal to an aggregate amount of up to $3,000,000 for all Buyers.

 

 

 

    	 	1	 

     

    

 

(iii)         
First Closing. On the First Closing Date (as defined below), the Company shall issue
and sell to the Buyer and the Buyer agrees to purchase from the Company, those certain Securities at such Purchase Prices set forth
in the “First Closing” section of the Schedule of Buyers. Subject to the satisfaction (or written waiver) of
the conditions thereto set forth in Section 6 and Section 7 below, the date and time of such initial issuance and
sale of pursuant to this Agreement shall be 5:00 P.M., Eastern Standard Time, on the Effective Date, or such other mutually agreed
upon time (the “First Closing Date”). Such initial closing of the transactions contemplated by this Agreement
(the “First Closing”) shall occur on the Initial Closing Date at such location as may be agreed to by the parties.
At the First Closing, the Company shall deliver all Commitment Shares issuable pursuant to this Agreement to the Buyers as set
forth in column (7) on the Schedule of Buyers.

 

(iv)          
Second Closing. On the Second Closing Date (as defined below), the Company shall issue
and sell to the Buyer and the Buyer agrees to purchase from the Company those certain Securities at such Purchase Prices set forth
in the “Second Closing” section of the Schedule of Buyers. Subject to the satisfaction (or written waiver) of
the conditions set forth in Section 6 and Section 7, the date and time of such issuance will be 5:00 P.M., Eastern
Standard Time, on the earliest Business Day following the satisfaction (or written waiver) of such conditions, but the Buyers shall
only be obligated to purchase the Securities if such date is after the forty-fifth (45th) day following the First Closing Date
but before the ninetieth (90th) day following the First Closing Date (the “Second Closing Date”) provided that,
notwithstanding anything contained herein, EMA Financial, LLC shall not be obligated to purchase any Securities at the Second Closing
(as defined below) but may participate in such Second Closing to the extent it elects to purchase Securities in its sole discretion..
Such second closing of the transactions contemplated by this Agreement (the “Second Closing”) shall occur on
the Second Closing Date at such location as may be agreed to by the parties. The First Closing and the Second Closing are both
referred to herein as “Closings.” The First Closing Date and the Second Closing Date are both referred to herein
as “Closing Dates.” 

 

(v)            
Form of Payment. At each Closing, (A) each Buyer shall deliver to the Company its portion
of the Purchase Price for the Notes and Warrants to be issued and sold to such Buyer at the Closing by wire transfer of immediately
available funds in accordance with the Company’s written wire instructions and (B) the Company shall deliver to each Buyer
the Notes and related Warrants which such Buyer is purchasing hereunder, in each case duly executed on behalf of the Company and
registered in the name of such Buyer or its designee.

 

2.              
BUYER’S REPRESENTATIONS AND WARRANTIES.

 

Each Buyer, severally
and not jointly, represents and warrants with respect to only itself, as of the Execution Date and as of the First Closing, and,
if applicable, the Second Closing that:

 

(a)            
Organization; Authority. Such Buyer is duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate
the transactions contemplated by the Transaction Documents (as defined below) to which it is a party and otherwise to carry out
its obligations hereunder and thereunder.

 

(b)            
No Public Sale or Distribution. Such Buyer is (i) acquiring the Notes and the Warrants,
(ii) upon conversion of the Notes will acquire the In-Kind Payment Shares and (iii) upon exercise of the Warrants (other than pursuant
to a Cashless Exercise (as defined in the Warrants)) will acquire the Warrant Shares issuable upon exercise of the Warrants, in
each case, for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof,
except pursuant to sales registered or exempted under the 1933 Act; provided, however, that by making the representations herein,
such Buyer does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to dispose
of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the 1933 Act. Such
Buyer is acquiring the Securities hereunder in the ordinary course of its business. Such Buyer does not presently have any agreement
or understanding, directly or indirectly, with any Person (as defined below) to distribute any of the Securities. For purposes
of this Agreement, “Person” means an individual, a limited liability company, a partnership, a joint venture,
a corporation, a trust, an unincorporated organization and a government or any department or agency thereof.

 

(c)            
Accredited Investor Status. Such Buyer is an “accredited investor” as that
term is defined in Rule 501(a) of Regulation D.

 

(d)            
Reliance on Exemptions. Such Buyer understands that the Securities are being offered
and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities
laws and that the Company is relying in part upon the truth and accuracy of, and such Buyer’s compliance with, the representations,
warranties, agreements, acknowledgments and understandings of such Buyer set forth herein in order to determine the availability
of such exemptions and the eligibility of such Buyer to acquire the Securities.

 

 

 

    	 	2	 

     

    

 

(e)            
Information. Such Buyer and its advisors, if any, have been furnished with all materials
relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities
that have been requested by such Buyer in writing. Such Buyer and its advisors, if any, have been afforded the opportunity to ask
questions of the Company. Neither such inquiries nor any other due diligence investigations conducted by such Buyer or its advisors,
if any, or its representatives shall modify, amend or affect such Buyer’s right to rely on the Company’s representations
and warranties contained herein. Such Buyer understands that its investment in the Securities involves a high degree of risk. Such
Buyer has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with
respect to its acquisition of the Securities.

 

(f)             
No Governmental Review. Such Buyer understands that no United States federal or state
agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities
or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits
of the offering of the Securities.

 

(g)            
Transfer or Resale. Such Buyer understands that (i) the Securities have not been and
are not being registered under the 1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred
unless (A) subsequently registered thereunder, or (B) sold, assigned or transferred pursuant to an exemption therefrom. Notwithstanding
the foregoing, the Securities may be pledged in connection with a bona fide margin account or other loan or financing arrangement
secured by the Securities and such pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities
hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or any other Transaction Document (as defined in Section 3(b)),
including, without limitation, this Section 2(g). 

 

(h)            
Legends.

 

(i)             
Such Buyer understands that the certificates or other instruments representing the Notes and
the Warrants, until such time as the resale of the In-Kind Payment Shares and the Warrant Shares have been registered under the
1933 Act, the stock certificates representing the In-Kind Payment Shares and the Warrant Shares, except as set forth below, shall
bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of such
stock certificates):

 

[NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE][EXERCISABLE] HAVE BEEN][THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE
FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
SECURED BY THE SECURITIES.

 

At any time after the Execution Date, the
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of the Securities
upon which it is stamped or, if available, issue to such holder by electronic delivery at the applicable balance account at The
Depository Trust Company (“DTC”), if (i) such Securities are registered for resale under the 1933 Act, (ii)
in connection with a sale, assignment or other transfer (other than pursuant to Rule 144), such holder provides the Company with
an opinion of counsel, in a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities may
be made without registration under the applicable requirements of the 1933 Act, or (iii) the Securities can be sold, assigned or
transferred pursuant to Rule 144 or Rule 144A. The Company shall be responsible for the issuance fees of its transfer agent, its
legal counsel (with respect to legal opinions from its counsel covering all the Buyers in any such opinion upon any sale pursuant
to Rule 144) and all DTC fees associated with such issuance.

 

 

 

    	 	3	 

     

    

 

(i)             
Validity; Enforcement. This Agreement and the other Transaction Documents to which
such Buyer is a party have been duly and validly authorized, executed and delivered on behalf of such Buyer and shall constitute
the legal, valid and binding obligations of such Buyer enforceable against such Buyer in accordance with their respective terms,
except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies.

 

(j)             
No Conflicts. The execution, delivery and performance by such Buyer of this Agreement
and the other Transaction Documents to which such Buyer is a party and the consummation by such Buyer of the transactions contemplated
hereby and thereby will not (i) result in a violation of the organizational documents of such Buyer or (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Buyer is a party,
or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations
which would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such
Buyer to perform its obligations hereunder.

 

(k)            
No Bad Actor Disqualification Event. Such Buyer represents, after reasonable inquiry,
that none of the “Bad Actor” disqualifying events described in Rule 506(d)(l)(i) to (viii) under the Securities Act
(a “Disqualification Event”) is applicable to such Buyer or any of its Rule 506(d) Related Parties (if any),
except a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) applies. “Rule 506(d) Related Party”
means a person or entity that is a beneficial owner of such Buyer’s securities for purposes of Rule 506(d).

 

3.              
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The Company represents
and warrants to each of the Buyers that, as of the Execution Date and as of the First Closing and the Second Closing:

 

(a)            
Organization and Qualification. Each of the Company and its “Subsidiaries”
(which for purposes of this Agreement means any joint venture or any entity in which the Company, directly or indirectly, owns
more than 10% of the capital stock or holds an equivalent equity or similar interest) are entities duly organized and validly existing
and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authorization
to own their properties and to carry on their business as now being conducted. Each of the Company and its Subsidiaries is duly
qualified as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property or
the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified
or be in good standing would not reasonably be expected to have a Material Adverse Effect. As used in this Agreement, “Material
Adverse Effect” means any material adverse effect on the business, properties, assets, operations, results of operations,
condition (financial or otherwise) or prospects of the Company and its Subsidiaries, individually or taken as a whole, or on the
transactions contemplated hereby or in the other Transaction Documents or by the agreements and instruments to be entered into
in connection herewith or therewith, or on the authority or ability of the Company to perform its obligations under the Transaction
Documents. As used in this Agreement, any adverse event that does not have a long-term effect on the Company is not a Material
Adverse Effect. For purposes of this subsection, “long-term effect” means an effect lasting more than twelve (12) months.
The Company has no Subsidiaries, except as set forth on Schedule 3(a). 

 

(b)            
Authorization; Enforcement; Validity. The Company has the requisite corporate power
and authority to enter into and perform its obligations under this Agreement, the Commitment Shares, the Notes, the Warrants, and
each of the other agreements entered into by the parties hereto in connection with the transactions contemplated by this Agreement
(collectively, the “Transaction Documents”) and to issue the Securities in accordance with the terms hereof
and thereof. The execution and delivery of the Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated hereby and thereby, including, without limitation, the issuance of the Notes and Warrants and the reservation
for issuance and the issuance of the In-Kind Payment Shares issuable pursuant to the terms of the Notes and the reservation for
issuance and issuance of Warrant Shares issuable upon exercise of the Warrants have been duly authorized by the Company’s
Board of Directors and in accordance with any other filings as may be required by any state securities agencies) no further filing,
consent, or authorization is required by the Company, its board of directors or its stockholders. This Agreement and the other
Transaction Documents of even date herewith have been duly executed and delivered by the Company, and constitute the legal, valid
and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such
enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

 

 

    	 	4	 

     

    

 

(c)            
Issuance of Securities. The issuance of the Commitment Shares, the Notes and the Warrants
have been duly authorized and upon issuance in accordance with the terms of the Transaction Documents shall be validly issued and
free from all taxes, liens and charges with respect to the issue thereof, and the Notes and Warrants shall be entitled to the rights
and preferences set forth therein. As of the First Closing Date, the Company shall have reserved from its duly authorized capital
stock fifteen million (15,000,000) shares of Common Stock to be issuable solely pursuant to the terms of the Notes or upon exercise
of the Warrants. Upon issuance or conversion in accordance with the Notes or the exercise of the Warrants and payment of the exercise
price under the Warrants (including by Cashless Exercise) thereunder, the Conversion Shares and the Warrant Shares, respectively,
will be validly issued, fully paid and nonassessable and free from all preemptive or similar rights, taxes, liens and charges with
respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. Assuming the
accuracy of each of the representations and warranties set forth in Section 2 of this Agreement, the offer and issuance
by the Company of the Securities is exempt from registration under the 1933 Act. This Section 3(c) is subject to the same
limitation described in the second to last sentence of Section 3(b).

 

(d)            
No Conflicts. The execution, delivery and performance of the Transaction Documents
by the Company and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation,
the issuance of the Notes and the Warrants, and reservation for issuance and issuance of the In-Kind Payment Shares and the Warrant
Shares) will not (i) result in a violation of any articles of incorporation, any certificate of formation, any certificate of designations
or other constituent documents of the Company or any of its Subsidiaries, any capital stock of the Company or any of its Subsidiaries
or the bylaws of the Company or any of its Subsidiaries or (ii) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) in any respect under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party,
or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including foreign, federal and state laws
and regulations) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of
its Subsidiaries is bound or affected.

 

(e)            
Consents. Neither the Company nor any of its Subsidiaries is required to obtain any
consent, authorization or order of, or make any filing or registration with, any government, court, regulatory, self-regulatory,
administrative agency or commission or other governmental agency, authority or instrumentality, domestic or foreign, of competent
jurisdiction (a “Governmental Authority”) or any other Person in order for it to execute, deliver or perform
any of its obligations under or contemplated by the Transaction Documents, in each case in accordance with the terms hereof or
thereof, except for (i) the filing of a Form D pursuant to Regulation D promulgated by the SEC under the 1933 Act and (ii) the
filings required by applicable state “blue sky” securities laws, rules and regulations. The Company and its Subsidiaries
are unaware of any facts or circumstances that might prevent the Company from obtaining or effecting any of the registration, application
or filings pursuant to the preceding sentence.

 

(f)             
Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges
and agrees that each Buyer is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction
Documents and the transactions contemplated hereby and thereby and that no Buyer is (i) an officer or director of the Company or
any of its Subsidiaries, or (ii) an “affiliate” (as defined in Rule 144) of the Company or any of its Subsidiaries.
The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company or any of its Subsidiaries
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby, and
any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents and the transactions
contemplated hereby and thereby is merely incidental to such Buyer’s purchase of the Securities. The Company further represents
to each Buyer that the Company’s decision to enter into the Transaction Documents has been based solely on the independent
evaluation by the Company and its representatives.

 

(g)            
No General Solicitation; Placement Agent. Neither the Company, nor any of its Subsidiaries
or affiliates, nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D) in connection with the offer or sale of the Securities. Neither the Company nor any of its
Subsidiaries has engaged any placement agent or other agent in connection with the sale of the Securities, except for RK Equity
Advisors, LLC. In the event that a broker-dealer or other agent or advisory is engaged by the Company subsequent to the initial
Closing, the Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, or brokers’
commissions (other than for persons engaged by any Buyer or its investment advisor) relating to or arising out of the transactions
contemplated hereby in connection with the sale of the Securities. The Company shall pay, and hold each Buyer harmless against,
any liability, loss or expense (including, without limitation, attorney’s fees and out-of-pocket expenses) arising in connection
with any such claim. 

 

 

 

    	 	5	 

     

    

 

(h)            
No Integrated Offering. None of the Company, its Subsidiaries, any of their affiliates,
and any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers
to buy any security, under circumstances that would require registration of any of the Securities under the 1933 Act, whether through
integration with prior offerings or otherwise, or caused this offering of the Securities to require approval of stockholders of
the Company for purposes of any applicable stockholder approval provisions, including, without limitation, under the rules and
regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or designated,
but excluding stockholder consents required to authorize and issue the Securities or waive any anti-dilution provisions in connection
therewith. None of the Company, its Subsidiaries, their affiliates and any Person acting on their behalf will take any action or
steps referred to in the preceding sentence that would require registration of any of the Securities under the 1933 Act or cause
the offering of the Securities to be integrated with other offerings for purposes of any such applicable stockholder approval provisions.

 

(i)             
Dilutive Effect. The Company understands and acknowledges that the number of In-Kind
Payment Shares issuable upon conversion of the Notes will increase in certain circumstances. The Company further acknowledges that
its obligation to issue In-Kind Payment Shares upon conversion of the Notes in accordance with this Agreement and the Notes, and
its obligation to issue the Warrant Shares upon exercise of the Warrants in accordance with this Agreement and the Warrants, is,
in each case, not limited by the dilutive effect that such issuance may have on the ownership interests of other stockholders of
the Company.

 

(j)             
Application of Takeover Protections; Rights Agreement. The Company and its board of
directors have taken all necessary actions, if any, in order to render inapplicable any stockholder rights plan or similar arrangement
if any relating to accumulations of beneficial ownership of Common Stock or a change in control of the Company.

 

(k)            
Material Liabilities; Financial Statements. The Company has no liabilities or obligations,
absolute or contingent (individually or in the aggregate), except (i) liabilities and obligations incurred after October 31, 2016
in the ordinary course of business that are not material and (ii) obligations under contracts made in the ordinary course of business
that would not be required to be reflected in financial statements prepared in accordance with generally accepted accounting principles
as applied in the United States, consistently applied for the periods covered thereby (“GAAP”). The financial
statements of the Company delivered to the Buyers on or prior to the Execution Date are a correct and complete copy of the audited
financial statements (including, in each case, any related notes thereto) of the Company and its Subsidiaries, on a consolidated
basis, for the fiscal years ended October 31, 2016 and 2015 and the quarter ended July 31, 2017, which have been filed with the
SEC (the “Financial Statements”), and such statements fairly present in all material respects the financial
position of the Company and its Subsidiaries, on a consolidated basis, at the respective dates thereof and the results of its operations
and cash flows for the periods indicated. The Financial Statements do not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, except as disclosed on Schedule 3(k). 

 

(l)             
Absence of Certain Changes. Since July 31, 2017, there has been no material adverse
change and no material adverse development in the business, assets, properties, operations, condition (financial or otherwise),
results of operations or prospects of the Company or its Subsidiaries. Without limiting the generality of the foregoing, neither
the Company nor any of its Subsidiaries has:

 

(i)             
declared, set aside or paid any dividend or other distribution with respect to any shares
of capital stock of the Company or any of its Subsidiaries or any direct or indirect redemption, purchase or other acquisition
of any such shares;

 

(ii)           
sold, assigned, pledged, encumbered, transferred or other disposed of any tangible asset of
the Company or any of its Subsidiaries (other than sales or the licensing of its products to customers in the ordinary course of
business consistent with past practice), or sold, assigned, pledged, encumbered, transferred or other disposed of any Intellectual
Property (other than licensing of products of the Company or its Subsidiaries in the ordinary course of business and on a non-exclusive
basis);

 

(iii)         
entered into any licensing or other agreement with regard to the acquisition or disposition
of any Intellectual Property (as hereinafter defined) other than licenses in the ordinary course of business consistent with past
practice or any amendment or consent with respect to any licensing agreement filed or required to be filed with respect to any
Governmental Authority;

 

(iv)          
affected capital expenditures, individually or in the aggregate, in excess of $100,000;

 

(v)            
created/allowed the creation of any Lien on any property of the Company or any of its Subsidiaries
except for Permitted Liens and Liens in existence on the Execution Date that are described on Schedules 3(m) or 3(s);

 

(vi)          
affected any payment, discharge, satisfaction or settlement of any suit, action, claim, arbitration,
proceeding or obligation of the Company or any of its Subsidiaries, except in the ordinary course of business and consistent with
past practice;

 

 

 

    	 	6	 

     

    

 

(vii)        
affected any split, combination or reclassification of any equity securities;

 

(viii)      
sustained any material loss, destruction or damage to any property of the Company or any Subsidiary,
whether or not insured;

 

(ix)          
made any acceleration or prepayment of any Indebtedness (as defined below) for borrowed money
or the refunding of any such Indebtedness;

 

(x)            
sustained any labor trouble involving the Company or any Subsidiary or any material change
in their personnel or the terms and conditions of employment;

 

(xi)          
affected any waiver of any valuable right, whether by contract or otherwise;

 

(xii)        
entered into any loan or extension of credit to any officer or employee of the Company;

 

(xiii)      
affected any change in the independent public accountants of the Company or its Subsidiaries
or any material change in the accounting methods or accounting practices followed by the Company or its Subsidiaries, as applicable,
or any material change in depreciation or amortization policies or rates;

 

(xiv)      
sustained any resignation or termination of any officer, key employee or group of employees
of the Company or any of its Subsidiaries;

 

(xv)        
affected any change in any compensation arrangement or agreement with any employee, officer,
director or stockholder that would result in the aggregate compensation to such Person in such year to exceed $150,000;

 

(xvi)      
affected any material increase in the compensation of employees of the Company or its Subsidiaries
(including any increase pursuant to any written bonus, pension, profit sharing or other benefit or compensation plan, policy or
arrangement or commitment), or any increase in any such compensation or bonus payable to any officer, stockholder, director, consultant
or agent of the Company or any of its Subsidiaries having an annual salary or remuneration in excess of $100,000; 

 

(xvii)    
undergone any revaluation of any of their respective assets, including, without limitation,
writing down the value of capitalized inventory or writing off notes or accounts receivable or any sale of assets other than in
the ordinary course of business; 

 

(xviii)   
affected any acquisition or disposition of any material assets (or any contract or arrangement
therefor), or any other material transaction by the Company or any Subsidiary otherwise than for fair value in the ordinary course
of business; 

 

(xix)      
written-down the value of any asset of the Company or its Subsidiaries or written-off as uncollectible
of any accounts or notes receivable or any portion thereof except in the ordinary course of business and in a magnitude consistent
with historical practice;

 

(xx)        
cancelled any debts or claims or any material amendment, termination or waiver of any rights
of the Company or its Subsidiaries; or

 

(xxi)      
entered into any agreement, whether in writing or otherwise, to take any of the actions specified
in the foregoing items (i) through (xxi).

 

Neither the Company nor any of its Subsidiaries
has taken any steps to seek protection pursuant to any bankruptcy law nor does the Company have any knowledge or reason to believe
that its creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact that would reasonably
lead a creditor to do so.

 

 

 

    	 	7	 

     

    

 

 

(m)          
No Undisclosed Events, Liabilities, Developments or Circumstances. Except as set forth
in Schedule 3(m) hereto, the Company and its Subsidiaries have no liabilities or obligations of any nature (whether accrued,
absolute, contingent, unasserted or otherwise and whether due or to become due) other than those liabilities or obligations that
are disclosed in the Company’s SEC filings and Financial Statements or which do not exceed, individually in excess of $50,000
and in the aggregate in excess of $250,000. The reserves, if any, established by the Company or the lack of reserves, if applicable,
are reasonable based upon facts and circumstances known by the Company on the Execution Date and there are no loss contingencies
that are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting Standards Board
which are not provided for in the Financial Statements. Schedule 3(m) also sets forth those liabilities and obligations
of the Company that shall be satisfied with the proceeds of the transaction contemplated by this Agreement.

 

(n)            
Conduct of Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries
is in violation of any term of or in default under its Articles of Incorporation, any certificate of designation, preferences or
rights of any other outstanding series of preferred stock of the Company or the Bylaws (as defined in Section 3(r)) or their
organizational charter or articles of incorporation or bylaws, respectively. Neither the Company nor any of its Subsidiaries is
in violation of any judgment, decree or order or any statute, ordinance, rule or regulation (each a “Legal Requirement”)
applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct its business
in violation of any of the foregoing, except for possible violations which could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect. The Company and its Subsidiaries possess all certificates, authorizations and permits
issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to
possess such certificates, authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect,
and neither the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification
of any such certificate, authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding
upon the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is a party which has or could reasonably
be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries,
any acquisition of property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries
as currently conducted other than such effects, individually or in the aggregate, which have not had and could not reasonably be
expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.

 

(o)            
Foreign Corrupt Practices. Neither the Company nor any of its Subsidiaries nor any
director, officer, agent, employee or other Person acting on behalf of the Company or any of its Subsidiaries has, in the course
of its actions for, or on behalf of, the Company or any of its Subsidiaries (i) used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment
to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision
of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment to any foreign or domestic government official or employee.

 

(p)            
Management. During the past five year period, no current officer or director of the
Company or any of its Subsidiaries has been the subject of: 

 

(i)             
a petition under bankruptcy laws or any other insolvency or moratorium law or has a receiver,
fiscal agent or similar officer been appointed by a court for such Person, or any partnership in which such person was a general
partner at or within two years before the time of such filing, or any corporation or business association of which such person
was an executive officer at or within two years before the time of such filing;

 

(ii)           
a conviction in a criminal proceeding or a named subject of a pending criminal proceeding
(excluding traffic violations that do not relate to driving while intoxicated or driving under the influence);

 

(iii)         
any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court
of competent jurisdiction, permanently or temporarily enjoining any such person from, or otherwise limiting, the following activities:

 

(1)            
Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity
pool operator, floor broker, leverage transaction merchant, any other person regulated by the United States Commodity Futures Trading
Commission or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities,
or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company,
or engaging in or continuing any conduct or practice in connection with such activity;

 

 

 

    	 	8	 

     

    

 

(2)            
Engaging in any type of business practice; or

 

(3)            
Engaging in any activity in connection with the purchase or sale of any security or commodity
or in connection with any violation of securities laws or commodities laws;

 

(iv)          
any order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority
barring, suspending or otherwise limiting for more than 60 days the right of any such person to engage in any activity described
in the preceding sub paragraph, or to be associated with persons engaged in any such activity;

 

(v)            
a finding by a court of competent jurisdiction in a civil action or by the SEC or other authority
to have violated any securities law, regulation or decree and the judgment in such civil action or finding by the SEC or any other
authority has not been subsequently reversed, suspended or vacated; or

 

(vi)          
a finding by a court of competent jurisdiction in a civil action or by the Commodity Futures
Trading Commission to have violated any federal commodities law, and the judgment in such civil action or finding has not been
subsequently reversed, suspended or vacated.

 

(q)            
Transactions With Affiliates. Except as disclosed in the Company’s SEC filings,
no current employee, director, officer or, to the knowledge of the Company, any former employee, director or officer, any stockholder
of the Company or its Subsidiaries, affiliate of any thereof who occupied such role during the past 12 months, (i) a party to any
transaction with the Company or its Subsidiaries (including any contract, agreement or other arrangement providing for the furnishing
of services by, or rental of real or personal property from, or otherwise requiring payments to, any such director, officer or
stockholder or such associate or affiliate or relative) or (ii) the direct or indirect owner of an interest in any corporation,
firm, association or business organization which is a competitor, supplier or customer of the Company or its Subsidiaries (except
for a passive investment (direct or indirect) in less than 5% of the common stock of a company whose securities are publicly traded
on or quoted), nor does any such Person receive income from any source other than the Company or its Subsidiaries which relates
to the business of the Company or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No employee, officer,
stockholder or director of the Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company
or its Subsidiaries, as the case may be, nor is the Company or any of its Subsidiaries indebted (or committed to make loans or
extend or guarantee credit) to any of them, other than (i) for payment of salary for services rendered, (ii) reimbursement for
reasonable expenses incurred on behalf of the Company, and (iii) for other standard employee benefits made generally available
to all employees or executives (including stock option agreements outstanding under any stock option plan approved by the board
of directors of the Company).

 

(r)             
Equity Capitalization. As of the Execution Date, the authorized capital stock of the
Company consists of 100,000,000 shares of Common Stock. The capitalization of the Company immediately prior to each Closing is
set forth on Schedule 3(r)(A) attached hereto and the capitalization of the Company immediately following each Closing is
set forth on Schedule 3(r)(B) attached hereto. All of such outstanding shares have been, or upon issuance will be, validly
issued and are fully paid and nonassessable. Except as disclosed in Schedule 3(r)(C): (i) none of the Company’s capital
stock is subject to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company;
(ii) there are no outstanding options, scrip, rights to subscribe to, or calls, exercisable or exchangeable for, any capital stock
of the Company or any of its Subsidiaries; (iii) there are no outstanding, credit agreements, credit facilities evidencing Indebtedness
of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become bound; (iv) there
are no financing statements securing obligations in any material amounts, either singly or in the aggregate, filed in connection
with the Company or any of its Subsidiaries; (v) there are no agreements or arrangements under which the Company or any of its
Subsidiaries is obligated to register the sale of any of their securities under the 1933 Act; (vi) there are no outstanding securities
or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a
security of the Company or any of its Subsidiaries; (vii) there are no securities or instruments containing anti-dilution or similar
provisions that will be triggered by the issuance of the Securities; (viii) the Company has not issued any stock appreciation rights
or “phantom stock” or any similar rights; and (ix) the Company and its Subsidiaries have no liabilities or obligations
required to be disclosed in the Financial Statements in accordance with GAAP but not so disclosed in the Financial Statements.
The Company has furnished to the Buyers true, correct and complete copies of the Company’s Articles of Incorporation, as
amended and as in effect on the date hereof (the “Articles of Incorporation”), and the Company’s Bylaws,
as amended and as in effect on the date hereof (the “Bylaws”), and the terms of all securities convertible into,
or exercisable or exchangeable for, shares of Common Stock and the material rights of the holders thereof in respect thereto.

 

 

 

    	 	9	 

     

    

 

 

(s)            
Indebtedness and Other Contracts. Except for Permitted Liens and as disclosed in the
Company’s Financial Statements and SEC filings or on Schedule 3(s), neither the Company nor any of its Subsidiaries
(i) has any outstanding Indebtedness (as defined below), (ii) is a party to any contract, agreement or instrument, the violation
of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected
to result in a Material Adverse Effect, (iii) is in violation of any term of or in default under any contract, agreement or instrument
relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in
a Material Adverse Effect, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance
of which, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. Schedule 3(s)
provides a description of the material terms of any such outstanding Indebtedness. For purposes of this Agreement: (x) “Indebtedness”
of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services (including, without limitation, “capital leases” in accordance
with GAAP) (other than trade payables entered into in the ordinary course of business consistent with past practice), (C) all reimbursement
or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced
by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition
of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention
agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness
(even though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession
or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in GAAP, consistently applied
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)
above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by)
any mortgage, deed of trust. lien, pledge, charge, security interest, easement, covenant, right of way, restriction, equity or
encumbrance of any nature whatsoever in or upon any property or assets (including accounts and contract rights) with respect to
any asset (a “Lien”) owned by any Person, even though the Person which owns such assets or property has not
assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect of indebtedness or
obligations of others of the kinds referred to in clauses (A) through (G) above; and (y) “Contingent Obligation”
means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any indebtedness,
lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability,
or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged,
or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole
or in part) against loss with respect thereto, and (z) “Permitted Liens” means: (a) Liens for current Taxes
or other governmental charges, assessments or levies that are not yet due and payable, and (b) landlord’s, mechanic’s,
carrier’s, workmen’s, repairmen’s or other similar Liens arising or incurred in the ordinary course of business
which are not, individually or in the aggregate, material to the business or the Company.

 

(t)             
Absence of Litigation. There is no action, suit, arbitration or other legal, administrative
or other governmental investigation, inquiry or proceeding (whether federal, state, local or foreign) pending or, to the best of
the Company’s knowledge, threatened against or affecting the Company or any of its Subsidiaries or any of their respective
properties, assets, capital stock or businesses or any of the Company’s or any of its Subsidiaries’ officers or directors.
After reasonable inquiry of its employees, the Company is not aware of any fact which might result in or form the basis for any
such action, suit, arbitration, investigation, inquiry or other proceeding. Neither the Company nor any of its Subsidiaries is
subject to any order, writ, judgment, injunction, decree, determination or award of any Governmental Authority.

 

(u)            
Employee Matters; Benefit Plans. 

 

(i)             
The employment of each officer and employee of the Company is terminable at the will of the
Company, except as disclosed on Schedule 3(u). The Company and its Subsidiaries have complied in all material respects with
all applicable laws relating to wages, hours, equal opportunity, collective bargaining, workers’ compensation insurance and
the payment of social security and other taxes. The Company is not aware that any officer, key employee or group of employees intends
to terminate his, her or their employment with the Company or its Subsidiaries, as the case may be, nor does the Company have a
present intention, or know of a present intention of its Subsidiaries, to terminate the employment of any officer, key employee
or group of employees. There are no pending or, to the knowledge of the Company, threatened employment discrimination charges or
complaints against or involving the Company or its Subsidiaries before any federal, state, or local board, department, commission
or agency, or unfair labor practice charges or complaints, disputes or grievances affecting the Company or its Subsidiaries.

 

 

 

    	 	10	 

     

    

 

(ii)           
Since the Company’s inception, to the knowledge of the Company neither the Company nor
its Subsidiaries has experienced any labor disputes, union organization attempts or work stoppage due to labor disagreements. There
are no unfair labor practice charges or complaints against the Company or its Subsidiaries pending, or to the knowledge of the
Company, threatened before the National Labor Relations Board or any comparable state agency or authority. There are no written
or oral contracts, commitments, agreements, understandings or other arrangements with any labor organization, nor work rules or
practices agreed to with any labor organization or employee association, applicable to employees of the Company or any of its Subsidiaries,
nor is the Company or its Subsidiaries a party to, or bound by, any collective bargaining or similar agreement; there is not, and
since the Company’s inception there has not been, any representation of the employees of the Company or its Subsidiaries
by any labor organization and, to the knowledge of the Company, there are no union organizing activities among the employees of
the Company or its Subsidiaries, and to the knowledge of the Company, no question concerning representation has been raised or
is threatened respecting the employees of the Company or its Subsidiaries.

 

(iii)         
Schedule 3(u)(iii) contains a true, correct and complete list of each pension, retirement,
savings, deferred compensation and profit-sharing plan and each stock option, stock appreciation, stock purchase, performance share,
bonus or other incentive plan, severance plan, health, group insurance or other welfare plan, or other similar plan (whether written
or otherwise) and any “employee benefit plan” within the meaning of Section 3(3) of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”), under which the Company has any current or future obligation or
liability (including any potential, contingent or secondary liability under Title IV of ERISA) or under which any employee or former
employee (or beneficiary of any employee or former employee) of the Company has or may have any current or future right to benefits
(the term “plan” shall include any contract, agreement (including an employment or independent contractor agreement),
policy or understanding, each such plan being hereinafter referred to in this Agreement individually as a “Benefit Plan”).
The Company has delivered to each Buyer true, correct and complete copies of (i) each material Benefit Plan, including any amendments
thereto, (ii) the summary plan description, if any, for each Benefit Plan, including any summaries of material modifications made
since the most recent summary plan description, (iii) the latest annual report which has been filed with the Internal Revenue Service
(the “IRS”) for each Benefit Plan required to file an annual report, and (iv) the most recent IRS determination
letter for each Benefit Plan that is a pension plan (as defined in ERISA) intended to be qualified under Section 401(a) of the
Internal Revenue Code of 1986, as amended (the “Code”). Each Benefit Plan intended to be tax qualified under
Sections 401(a) and 501(a) of the Code is and has been determined by the IRS to be tax qualified under Sections 401(a) and 501(a)
of the Code and, since such determination, no amendment to or failure to amend any such Benefit Plan and no other event or circumstance
has occurred that could reasonably be expected to adversely affect its tax qualified status.

 

(iv)          
There are no actions, claims, audits, lawsuits or arbitrations pending, or, to the knowledge
of the Company, threatened, with respect to any Benefit Plan or the assets of any Benefit Plan. Each Benefit Plan has been administered
in all material respects in accordance with its terms and with all applicable Legal Requirements (including, without limitation,
the Code and ERISA). 

 

(v)            
The consummation of the transactions contemplated by this Agreement will not (1) entitle any
employee or independent contractor of the Company or its Subsidiaries to severance pay or termination benefits, (2) accelerate
the time of payment or vesting, or increase the amount of compensation due to any current or former employee or independent contractor
of the Company or its Subsidiaries, (3) obligate the Company or any of its affiliates to pay or otherwise be liable for any compensation,
vacation days, pension contribution or other benefits to any current or former employee, consultant, agent or independent contractor
of the Company or its Subsidiaries for periods before each Closing, (4) require assets to be set aside or other forms of security
to be provided with respect to any liability under a Benefit Plan, or (5) result in any “parachute payment” (within
the meaning of Section 280G of the Code) under any Benefit Plan.

 

(vi)          
No Benefit Plan is subject to the provisions of Section 412 of the Code or Part 3 of Subtitle
B of Title I of ERISA. No Benefit Plan is subject to Title IV of ERISA and no Benefit Plan is a “multiemployer plan”
(within the meaning of Section 3(37) of ERISA). Since inception, neither the Company, its Subsidiaries, nor any business or entity
treated as a single employer with the Company or its Subsidiaries for purposes of Title IV of ERISA contributed to or was obliged
to contribute to a pension plan that was at any time subject to Title IV of ERISA.

 

(vii)        
No Benefit Plan has provided, been required to provide, provides or is required to provide,
at any time in the past, present, or future, health, medical, dental, accident, disability, death or survivor benefits to or in
respect of any Person beyond one year following termination of employment, except to the extent required under any state insurance
law or under Part 6 of Subtitle B of Title I of ERISA and under Section 4980B of the Code. No Benefit Plan covers any individual
that is not an employee or advisor of the Company or its Subsidiaries, other than spouses and dependents of employees under health
and child care policies listed in Schedule 3(u)(vii), true and complete copies of which have been made available to each
Buyer.

 

 

 

    	 	11	 

     

    

 

Except as otherwise permitted pursuant
to employment agreements with the Company disclosed to the Buyers, each officer of the Company is currently devoting all of such
officer’s business time to the conduct of the business of the Company. Except as otherwise permitted pursuant to employment
agreements with the Company disclosed to the Buyers, the Company is not aware of any officer or key employee of the Company or
any of its Subsidiaries planning to work less than full time at the Company or its Subsidiaries in the future.

 

(v)            
Real Property. The Company does not hold title to, or hold a leasehold interest in,
any real property, other than customary office leases. Any real property and facilities held under lease by the Company and its
Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as would not have a Material
Adverse Effect.

 

(w)          
Intellectual Property. 

 

(i)             
Except as set forth on Schedule 3(w)(i), the Company and its Subsidiaries own all right,
title and interest in and to, or have a valid and enforceable license to use all the Intellectual Property used by them in connection
with the their respective businesses, which represents all intellectual property rights necessary to the conduct of the their business
as now conducted. The Company and its Subsidiaries are in material compliance with all contractual obligations relating to the
protection of such of the Intellectual Property as they use pursuant to license or other agreement. The conduct of the business
of the Company and its Subsidiaries as currently conducted or contemplated does not conflict with or infringe any proprietary right
or Intellectual Property of any third party, including, without limitation, the transmission, reproduction, use, display or modification
of any content or material (including framing, and linking web site content) on a web site, bulletin board or other like medium
hosted by or on behalf of the Company or any of its Subsidiaries, except for such infringements and conflicts which could not reasonably
be expected to have a Material Adverse Effect. There is no claim, suit, action or proceeding pending or threatened against the
Company or any Subsidiary: (i) alleging any such conflict or infringement with any third party’s proprietary rights; or (ii)
challenging the Company’s or any Subsidiary’s ownership or use of, or the validity or enforceability of any Intellectual
Property. 

 

(ii)           
Schedule 3(w)(ii) sets forth a complete and current list of registered trademarks or
copyrights, issued patents, applications thereof, or other forms of registration anywhere in the world that is owned by the Company
or a Subsidiary (“Listed Intellectual Property”) and the owner of record, date of application or issuance and
relevant jurisdiction as to each. All Listed Intellectual Property is owned by the Company or a Subsidiary, free and clear of security
interests, liens, encumbrances or claims of any nature. All Listed Intellectual Property is valid, subsisting, unexpired, in proper
form and enforceable and all renewal fees and other maintenance fees that have fallen due on or prior to the Execution Date have
been paid. No Listed Intellectual Property is the subject of any proceeding before any governmental, registration or other authority
in any jurisdiction, including any office action or other form of preliminary or final refusal of registration, except as noted
on Schedule 3(w)(ii). The consummation of the transactions contemplated hereby will not alter or impair in any material
respect any Intellectual Property that is owned or licensed by the Company or a Subsidiary.

 

(iii)         
Schedule 3(w)(iii) sets forth a complete list of all material agreements relating to
Intellectual Property to which the Company or a Subsidiary is a party, subject or bound (the “Intellectual Property Contracts”)
(other than agreements involving (A) the license of the Company of standard, generally commercially available “off-the-shelf”
third party products or (B) non-disclosure agreements). Each Intellectual Property Contract: (i) is valid and binding on the Company
or a Subsidiary, as the case may be, and the counterparties thereto, and is in full force and effect and (ii) upon consummation
of the transactions contemplated hereby shall continue in full force and effect without penalty or other adverse consequence. 

 

(iv)          
Except as disclosed on Schedule 3(w)(iv), the Company and its Subsidiaries are not
under any obligation to pay royalties or other payments in connection with any agreement, nor restricted from assigning their rights
respecting Intellectual Property nor will the Company or any Subsidiary otherwise be, as a result of the execution and delivery
of this Agreement or the performance of the Company’s obligations under this Agreement, in material breach of any agreement
relating to the Intellectual Property. 

 

(v)            
Except as disclosed on Schedule 3(w)(v), no present or former employee, officer or
director of the Company or any Subsidiary, or agent or outside contractor of the Company or any Subsidiary, holds any right, title
or interest, directly or indirectly, in whole or in part, in or to any Intellectual Property that is owned or licensed by the Company
or any Subsidiary. 

 

 

 

    	 	12	 

     

    

 

(vi)          
Except as disclosed on Schedule 3(w)(vi): (i) none of the Listed Intellectual Property
has been used, disclosed or appropriated to the detriment of the Company or any Subsidiary for the benefit of any Person other
than the Company; and (ii) no employee, independent contractor or agent of the Company or any Subsidiary has misappropriated any
trade secrets or other confidential information of any other Person in the course of the performance of his or her duties as an
employee, independent contractor or agent of the Company or any Subsidiary that would reasonably be expected to have a Material
Adverse Effect. 

 

(vii)        
Except as disclosed on Schedule 3(w)(vii), any programs, modifications, enhancements
or other inventions, improvements, discoveries, methods or works of authorship (“Works”) that were created by
employees of the Company or any Subsidiary were made in the regular course of such employees’ employment or service relationships
with the Company or its Subsidiary using the Company’s or the Subsidiary’s facilities and resources and, as such, constitute
either works made for hire or all rights and title to and in such Works have been fully assigned to the Company or a Subsidiary.

 

(viii)      
For the purpose of this Section 3(w), “Intellectual Property” shall
mean all of the following: (A) trademarks and service marks, trade dress, product configurations, trade names and other indications
of origin, applications or registrations in any jurisdiction pertaining to the foregoing and all goodwill associated therewith;
(B) inventions, discoveries, improvements, ideas, know-how, formula methodology, processes, technology, software (including password
unprotected interpretive code or source code, object code, development documentation, programming tools, drawings, specifications
and data) and applications and patents in any jurisdiction pertaining to the foregoing, including re-issues, continuations, divisions,
continuations-in-part, renewals or extensions; (C) trade secrets, including confidential information and the right in any jurisdiction
to limit the use or disclosure thereof; (D) copyrights in writings, designs software, mask works or other works, applications or
registrations in any jurisdiction for the foregoing and all moral rights related thereto; (E) database rights; (F) Internet Web
sites, domain names and applications and registrations pertaining thereto and all intellectual property used in connection with
or contained in all versions of the Company’s Web sites; (G) rights under all agreements relating to the foregoing; (H) books
and records pertaining to the foregoing; and (I) claims or causes of action arising out of or related to past, present or future
infringement or misappropriation of the foregoing. 

 

(x)            
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with any
and all Environmental Laws (as hereinafter defined), (ii) have received all permits, licenses or other approvals required of them
under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance with all terms and conditions
of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The term “Environmental Laws”
means all federal, state, local or foreign laws relating to pollution or protection of human health or the environment (including,
without limitation, ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation,
laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous
substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the
manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

 

(y)            
Subsidiary Rights. The Company or one of its Subsidiaries has the unrestricted right
to vote, and (subject to limitations imposed by applicable law) to receive dividends and distributions on, all capital securities
of its Subsidiaries as owned by the Company or such Subsidiary.

 

(z)            
Tax Status. 

 

(i)             
Except as disclosed on Schedule 3(z), the Company and its Subsidiaries have filed in
the appropriate jurisdictions all material returns, reports, information statements and other documentation required to be filed
or maintained, in connection with the calculation, determination, assessment or collection of any and all federal, state, local,
foreign and other taxes, levies, fees, imposts, duties, governmental fees and charges of whatever kind (including any interest,
penalties or additions to the tax imposed in connection therewith or with respect thereto), including, without limitation, taxes
imposed on, or measured by, income, franchise, profits, gross income or gross receipts, and also ad valorem, value added,
sales, use, service, real or personal property, capital stock, stock transfer, license, payroll, withholding, employment, social
security, workers’ compensation, unemployment compensation, utility, severance, production, excise, stamp, occupation, premium,
windfall profits, environmental, transfer and gains taxes and customs duties (each a “Tax”).

 

 

 

 

    	 	13	 

     

    

 

(ii)           
Each of the Company and its Subsidiaries has paid all material Taxes and other assessments
due from and payable by the Company and its Subsidiaries on or prior to the date hereof on a timely basis except as to those set
forth in Schedule 3(z)(ii). The charges, accruals, and reserves for Taxes with respect to the Company and its Subsidiaries
are adequate to cover Tax liabilities of the Company and its Subsidiaries accruing throughout the Execution Date. Except as set
forth in Schedule 3(z)(ii), each of the Company and its Subsidiaries has complied in all material respects with all applicable
Legal Requirements relating to the payment and withholding of Taxes (including withholding and reporting requirements under Sections
1441 through 1464, 3401 through 3406, and 6041 and 6049 of the Code and similar provisions under any other applicable Legal Requirements)
and, within the time and in the manner prescribed by law, has withheld from wages, fees and other payments and paid over to the
proper governmental or regulatory authorities all amounts required. Except as set forth in Schedule 3(z)(ii), neither the
Company nor any of its Subsidiaries has received notice of assessment or proposed assessment of any Taxes claimed to be owed by
it or any other Person on its behalf. Except as set forth in Schedule 3(z)(ii), no Returns filed by or on behalf of the
Company or any of its Subsidiaries with respect to Taxes are currently being audited or examined. Except as set forth in Schedule
3(z)(ii), neither the Company nor any of its Subsidiaries has received notice of any such audit or examination. Except as set
forth in Schedule 3(z)(ii), no issue has been raised by any taxing authority with respect to the Company or any of its Subsidiaries
in any audit or examination which, by application of similar principles, could reasonably be expected to result in a proposed material
adjustment to the liability for Taxes for any period not so examined.

 

(iii)         
Except as disclosed on Schedule 3(z)(iii), no known Liens have been filed against the
Company or any of its Subsidiaries with respect to any Taxes (other than Liens for Taxes not yet due and payable). Neither the
Company nor any of its Subsidiaries has elected pursuant to the Code to be treated as an S corporation or any comparable provision
of local, state or foreign law, or has made any other elections pursuant to the Code (other than elections that relate solely to
entity classification, methods of accounting, depreciation, or amortization) that would have a material effect on the business,
properties, prospects, or financial condition of the Company and its Subsidiaries, individually or in the aggregate. 

 

(iv)          
The Company has received notices and requests for information from the IRS and certain states
regarding its failure to file its Taxes. Neither the Company nor any of its Subsidiaries has been a member of an affiliated group
(as defined in Section 1504(a) of the Code) or filed or been included in a combined, consolidated or unitary income tax return
other than the affiliated group of which the Company is currently the common parent. Neither the Company nor any of its Subsidiaries
is required to include in income any adjustment pursuant to Section 481(a) of the Code by reason of a voluntary change in accounting
methods initiated by the Company or any of its Subsidiaries, and no Governmental Authority has proposed an adjustment or change
in accounting method. Neither the Company nor any of its Subsidiaries is a party to any Tax sharing or Tax indemnity agreement
or any other agreement of a similar nature that remains in effect. Neither the Company nor any of its Subsidiaries has consented
to any waiver of the statute of limitations for the assessment of any Taxes or has requested any extension of time for the payment
of any Taxes. Neither the Company nor any of its Subsidiaries has ever held a material beneficial interest in any other Person,
other than those listed in Schedule 3(z)(iv). Neither the Company nor any of its Subsidiaries is obligated to make, nor
as a result of any event connected with the transactions contemplated by this Agreement will become obligated to make, any payment
that would not be deductible under Section 280G of the Code. Neither the Company nor any Subsidiary of the Company is a “passive
foreign investment company” within the meaning of Section 1296 of the Code (a “PFIC”), and the Company
does not anticipate that the Company or any additional foreign Subsidiary will become a PFIC in the foreseeable future.

 

(aa)         
Internal Accounting and Disclosure Controls. Except as disclosed in the Company’s
SEC filings, the Company and each of its Subsidiaries maintain a system of internal accounting controls appropriate for its size.

 

(bb)        
Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship
between the Company and an unconsolidated or other off balance sheet entity that is not disclosed by the Company in its Financial
Statements or that otherwise would be reasonably likely to have a Material Adverse Effect.

 

(cc)         
Investment Company Status. The Company is not, and upon consummation of the sale of
the Securities will not be, an “investment company,” a company controlled by an “investment company” or
an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment
company” as such terms are defined in the Investment Company Act of 1940, as amended.

 

(dd)        
Illegal or Unauthorized Payments; Political Contributions Neither the Company or any
of its Subsidiaries nor, to the best of the Company’s knowledge (after reasonable inquiry of its officers and directors),
any of the officers, directors, employees, agents or other representatives of the Company or any of its Subsidiaries or any other
business entity or enterprise with which the Company or any Subsidiary is or has been affiliated or associated, has, directly or
indirectly, made or authorized any payment, contribution or gift of money, property, or services, whether or not in contravention
of applicable law, (a) as a kickback or bribe to any Person or (b) to any political organization, or the holder of or any aspirant
to any elective or appointive public office except for personal political contributions not involving the direct or indirect use
of funds of the Company or any of its Subsidiaries.

 

 

 

    	 	14	 

     

    

 

(ee)         
Transfer Taxes. As of each Closing, all stock transfer or other taxes (other than income
or similar taxes) which are required to be paid in connection with the sale and transfer of the Securities to be sold to each Buyer
hereunder will be, or will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will
have been complied with.

 

(ff)          
Books and Records. The books of account, ledgers, order books, records and documents
of the Company and its Subsidiaries accurately and completely reflect all information relating to the respective businesses of
the Company and its Subsidiaries, the nature, acquisition, maintenance, location and collection of each of their respective assets,
and the nature of all transactions giving rise to material obligations or accounts receivable of the Company or its Subsidiaries,
as the case may be, except where the failure to so reflect such information would not have a Material Adverse Effect. The minute
books of the Company and its Subsidiaries contain accurate records of all meetings and accurately reflect all other actions taken
by the stockholders, boards of directors and all committees of the boards of directors, and other governing Persons of the Company
and its Subsidiaries, respectively.

 

(gg)        
Money Laundering. The Company and its Subsidiaries are in compliance with, and have
not previously violated, the USA PATRIOT ACT of 2001 (the “PATRIOT Act”) and all other applicable U.S. and non-U.S.
anti-money laundering laws and regulations, including, but not limited to, the laws, regulations and Executive Orders and sanctions
programs administered by the U.S. Office of Foreign Assets Control (“OFAC”), including, but not limited, to
(i) Executive Order 13224 of September 23, 2001 entitled, “Blocking Property and Prohibiting Transactions With Persons Who
Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR,
Subtitle B, Chapter V (collectively, the “Anti-Money Laundering/OFAC Laws”).

 

(hh)        
 U.S. Real Property Holding Corporation. The Company is not, has never been, and so
long as any Securities remain outstanding, shall not become, a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon any Buyer’s request.

 

(ii)           
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject
to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors
of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or affiliates
owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities
or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling influence over the
management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(jj)           
Shell Company Status. The Company is not an issuer identified in Rule 144(i)(1)(i)
of the 1933 Act as of the Execution Date, however the Company is an issuer identified in Rule 144(i)(1)(ii) of the 1933 Act as
of the Execution Date. As of November 8, 2016, the Company filed all “Form 10” information as prescribed by Rule 144(i)(2)
of the 1933 Act, and as of November 8, 2017, holders of the Company’s securities will be eligible to rely on Rule 144 of
the 1933 Act regarding the removal of 1933 Act restrictions regarding the transfer and sale of shares thereunder. 

 

(kk)        
No Disqualification Events. With respect to Securities to be offered and sold hereunder
in reliance on Rule 506 under the 1933 Act (“Regulation D Securities”), none of the Company, any of its predecessors,
any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any
beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting
power, nor any promoter (as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at
the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered Persons”)
is subject to any Disqualification Event, except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company
has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company
has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Buyers a copy
of any disclosures provided thereunder.

 

(ll)           
Other Covered Persons. The Company is not aware of any Person (other than any Issuer
Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of Buyers or potential purchasers
in connection with the sale of any Regulation D Securities.

 

 

 

    	 	15	 

     

    

 

(mm)    
Disclosure. The Company understands and confirms that each of the Buyers will rely
on the foregoing representations in effecting transactions in securities of the Company. No statement made by the Company in this
Agreement, any other Transaction Document or the Exhibits and Schedules attached hereto or in any certificate or
schedule furnished or to be furnished by or on behalf of the Company to the Investors or any of their representatives in connection
with the transactions contemplated hereby contains any untrue statement of a material fact or omits to state a material fact necessary
in order to make the statements contained herein or therein not misleading. The due diligence materials previously provided by
or on behalf of the Company to each Buyer (the “Due Diligence Materials”), have been prepared in a good faith
effort by the Company to describe the Company’s present and proposed products, and projected growth and the Company and do
not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not
misleading, except that with respect to assumptions, projections and expressions of opinion or predictions contained in the Due
Diligence Materials, the Company represents only that such assumptions, projections, expressions of opinion and predictions were
made in good faith and that the Company believes there is a reasonable basis therefor. The Due Diligence Materials contain all
material agreements of the Company and its Subsidiaries and no material agreements of the Company or its Subsidiaries exist other
than those provided in the Due Diligence Materials. The Company acknowledges and agrees that no Buyer participated in the preparation
of, or has any responsibility for, the content of any Due Diligence Materials.

 

(nn)        
Sarbanes-Oxley. As may or may not be applicable, the Company is in compliance with
all provisions of the Sarbanes-Oxley Act of 2002, as amended, which are applicable to it as of the Effective Date.

 

(oo)        
Accountants. The Company’s accountants are set forth in the SEC filings and,
to the knowledge of the Company, such accountants are an independent registered public accounting firm as required by the Securities
Act.

 

(pp)        
No Market Manipulation. The Company has not, and to its knowledge no person acting
on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any
compensation for soliciting another to purchase any other securities of the Company.

 

(qq)        
Title to Assets. The Company owns good and marketable title, free and clear of all
Liens, to all of the personal property and assets reflected in the Financial Statements or acquired by it after the dates presented
in the Financial Statements, except for (A) assets which have been sold since the Financial Statements in the ordinary course
of business, (B) Liens securing liabilities reflected in the Financial Statements or incurred in the ordinary course of business,
(C) Liens for current Taxes not yet due and payable, and (D) Permitted Liens.

 

(rr)          
Breach of Representations and Warranties by the Company. If the Company breaches any
of the representations or warranties set forth in this Section 3 in any material respect, in addition to any other remedies
available to the Buyer pursuant to this Agreement, it will be considered an “Event of Default” under the Notes.

 

4.              
COVENANTS.

 

(a)            
Best Efforts. Each party shall use its commercially reasonable efforts timely to satisfy
each of the covenants below and the conditions to be satisfied by it as provided in Sections 6 and 7 of this Agreement.

 

(b)            
Use of Proceeds. 

 

(i)             
The Company will use the proceeds from the sale of the Securities in the First Closing to
fund the Company’s working capital. The Company will use the proceeds from the sale of the Securities in the Second Closing
to fund the closing of the contemplated transaction described and set forth on Schedule 4(b) to this Agreement (the “Contemplated
Transaction”). The Company shall not use any proceeds from the transactions contemplated by this Agreement, at any time,
to repay indebtedness (other than to the Buyers), to lend money, to give credit, or to advance funds to any of its officers, directors,
employees, or affiliates, other than as set forth on Schedule 4(b). 

 

(ii)           
In the event that the Contemplated Transaction has not been consummated by the 120th day following
the Execution Date, such shall constitute an “Event of Default” under the Notes, and all outstanding amounts thereunder
shall immediately become due and payable to the holders thereof. 

 

 

 

    	 	16	 

     

    

 

(c)            
Reporting Status. Until the date on which a Buyer or any transferee or assignee thereof
to whom a Buyer assigns its rights as a holder of Securities under this Agreement and/or the Notes (each an “Investor”,
and collectively, the “Investors”) shall have sold all of the In-Kind Payment Shares and Warrant Shares and
none of the Notes and Warrants is outstanding (the “Reporting Period”), the Company shall timely file all reports
required to be filed with the SEC pursuant to the Securities Exchange Act of 1934, as amended (the “1934 Act”),
and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or
the rules and regulations thereunder would no longer require or otherwise permit such termination. 

 

(d)            
Financial Information. As long as any Securities remain outstanding, the Company agrees
to send the following to each Investor during the Reporting Period (i) unless the following are filed with the SEC through EDGAR
and are available to the public through the EDGAR system, within one (1) Business Day after the filing thereof with the SEC, a
copy of its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, any Current Reports on Form 8-K (or any analogous reports
under the 1934 Act) and any registration statements (other than on Form S-8) or amendments filed pursuant to the 1933 Act, (ii)
on the same day as the release thereof, e-mailed copies of all press releases issued by the Company or any of its Subsidiaries,
and (iii) copies of any notices and other information made available or given to the stockholders of the Company generally, contemporaneously
with the making available or giving thereof to the stockholders. As used herein, “Business Day” means any day
other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized or required by law to
remain closed.

 

(e)            
Listing. The Company shall maintain the listing or quotation of the Common Stock on
the OTCQB, OTCQX or other securities market (any, a “Principal Market”, which shall not include the OTCPink
or Pinksheets), and neither the Company nor any of its Subsidiaries shall take any action which would be reasonably expected to
result in the delisting or suspension of the Common Stock on the Principal Market. The Company shall pay all fees and expenses
in connection with satisfying its obligations under this Section 4(e).

 

(f)             
Fees. Subject to Section 8 below, at the First Closing, the Company shall reimburse
SBI Investments LLC, 2014-1 (“Sea Otter”) or its designee(s) for all costs and expenses incurred in connection
with the transactions contemplated by the Transaction Documents (including all legal fees and disbursements in connection therewith,
documentation and implementation of the transactions contemplated by the Transaction Documents and due diligence in connection
therewith), which amount may be withheld by such Buyer from its Purchase Price at the Closing to the extent not previously reimbursed
by the Company. Notwithstanding the foregoing, in no event will the costs and expenses of Sea Otter reimbursed by the Company pursuant
to this Section 4(f) exceed $10,000.00 with respect to the Closings without the prior approval of the Company. The Company
shall be responsible for the payment of any placement agent’s fees, financial advisory fees, or broker’s commissions
relating to or arising out of the transactions contemplated hereby but only to the extent that the Company has agreed with any
such party to pay such fees. The Company shall pay, and hold each Buyer harmless against, any liability, loss or expense (including,
without limitation, reasonable attorney’s fees and out-of-pocket expenses) arising in connection with any claim relating
to any such payment. Except as otherwise set forth in the Transaction Documents, each party to this Agreement shall bear its own
expenses in connection with the sale of the Securities to the Buyers.

 

(g)            
Pledge of Securities. The Company acknowledges and agrees that the Securities may be
pledged by an Investor in connection with a bona fide margin agreement or other loan or financing arrangement that is secured by
the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder,
and no Investor effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or any other Transaction Document, including, without limitation, Section
2(g) hereof; provided that an Investor and its pledgee shall be required to comply with the provisions of Section 2(g)
hereof in order to effect a sale, transfer or assignment of Securities to such pledgee. The Company hereby agrees to execute and
deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities
to such pledgee by an Investor.

 

 

 

    	 	17	 

     

    

 

(h)            
Disclosure of Transactions and Other Material Information. On or before 9:30 a.m.,
New York time, on the first (1st) Business Day after each Closing, the Company shall file a Current Report on Form 8-K describing
all the material terms of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching
all the material Transaction Documents (including, without limitation, this Agreement and the forms of Note and Warrant all (together,
the “8-K Filing”). From and after the filing of the 8-K Filing, the Company shall have disclosed all material,
non-public information (if any) provided to any of the Buyers by the Company or any of its Subsidiaries or any of their respective
officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations
with respect to the Transaction Documents, whether written or oral, between the Company, any of its Subsidiaries or any of their
respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers or any of their affiliates,
on the other hand, shall terminate. The Company shall not, and shall cause each of its Subsidiaries and its and each of their respective
officers, directors, employees and agents, not to, provide any Buyer with any material, nonpublic information regarding the Company
or any of its Subsidiaries from and after the Execution Date without the express prior written consent of such Buyer. If a Buyer
has, or believes it has, received any such material, nonpublic information regarding the Company or any of its Subsidiaries, it
may provide the Company with written notice thereof. The Company shall, within two (2) Business Days of receipt of such notice,
make public disclosure of such material, nonpublic information. In the event of a breach of the foregoing covenant by the Company,
any of its Subsidiaries, or any of its or their respective officers, directors, employees and agents, in addition to any other
remedy provided herein or in the Transaction Documents, a Buyer shall have the right to make a public disclosure, in the form of
a press release, public advertisement or otherwise, of such material, nonpublic information without the prior approval by the Company,
its Subsidiaries, or any of its or their respective officers, directors, employees or agents. No Buyer shall have any liability
to the Company, its Subsidiaries, or any of its or their respective officers, directors, employees, stockholders or agents for
any such disclosure. To the extent that the Company delivers any material, non-public information to a Buyer without such Buyer’s
consent, such Buyer shall not have any duty of confidentiality with respect to, or a duty not to trade on the basis of, such material,
non-public information. Subject to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue any press releases
or any other public statements with respect to the transactions contemplated hereby; provided, however, that the
Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure with respect
to such transactions as is required by applicable law and regulations, provided that each Buyer shall be consulted by the Company
in connection with any such press release or other public disclosure prior to its release. Without the prior written consent of
any applicable Buyer, neither the Company nor any of its Subsidiaries or affiliates shall disclose the name of such Buyer in any
filing, announcement, release or otherwise, except as the Company has been advised by its counsel as may be required by law including
the Rules of the SEC or in response to written comments of the Staff of the SEC. 

 

(i)             
Additional Notes; Variable Securities. Except as provided for herein, so long as Sea
Otter or any other other Buyer beneficially owns at least ten percent (10%) of the Notes issued pursuant to this Agreement, the
Company will not issue any Notes other than to the Buyers as contemplated hereby and the Company shall not issue any other securities
that would cause a breach or default under the Notes or the Warrants. From the Execution Date until such time when no Buyer beneficially
owns more than ten percent (10%) of the Notes issued pursuant to this Agreement, the Company shall not, in any manner, issue or
sell any rights, warrants or options to subscribe for or purchase Common Stock or directly or indirectly convertible into or exchangeable
or exercisable for Common Stock at a price which varies with the market price of the Common Stock. 

 

(j)             
Corporate Existence. Corporate Existence. So long as any Buyer beneficially owns any
Securities, the Company shall maintain its corporate existence. So long as any Buyer beneficially owns at least ten percent (10%)
of the Notes issued pursuant to this Agreement, the Company shall not (i) complete any merger, business combination or consolidation
with or of another Person which would trigger a requirement of the Company to file with the SEC the historical financial statements
of such Person pursuant to Rule 8-04 of Regulation S-X of the 1933 Act (or Rule 3-05, if the Company is no longer a smaller reporting
company) unless, prior to completion of such transaction, management of the Company is reasonably certain that such other Person’s
financial statements can be audited by an accounting firm registered with the Public Company Accounting Oversight Board and prepared
in accordance with U.S. GAAP within a period of 60 days following the completion date of such transaction, (ii) directly or indirectly,
effect any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets
in one or a series of related transactions, or (iii) directly or indirectly, in one or more related transactions effect any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property. 

 

(k)            
Conduct of Business. The business of the Company and its Subsidiaries shall not be
conducted in violation of any law, ordinance or regulation of any governmental entity, except where such violations would not result,
either individually or in the aggregate, in a Material Adverse Effect. The Company and its Subsidiaries shall at all times be in
compliance with the Foreign Corrupt Practices Act; the PATRIOT Act, and all other applicable U.S. and non-U.S. anti-money laundering
laws and regulations; and the laws, regulations and Executive Orders and sanctions programs administered by the OFAC, including,
without limitation, the “Anti-Money Laundering/OFAC Laws”.

 

 

 

    	 	18	 

     

    

 

(l)             
Public Information. At any time during the period commencing on the Execution Date
and ending two years from the Execution Date, if (A) a registration statement is not available for the resale of all of the Securities,
and unless the Securities may be sold without restriction or limitation pursuant to Rule 144 and without the requirement to be
in compliance with Rule 144(c)(1) , if the Company shall (i) fail for any reason to satisfy the requirements of Rule 144(c)(1),
including, without limitation, the failure to satisfy the current public information requirement under Rule 144(c) or (ii) if the
Company becomes an issuer described in Rule 144(i)(1)(i), and the Company shall fail to satisfy any condition set forth in Rule
144(i)(2), and (B) any such failure continues for more than fifteen (15) Business Days (a “Public Information Failure”)
then, as partial relief for the damages to any holder of Securities by reason of any such delay in or reduction of its ability
to sell the Securities (which remedy shall not be exclusive of any other remedies available at law or in equity), the Company shall
pay to each such holder an amount in cash equal to one percent (1.0%) of the aggregate Purchase Price of such holder’s Notes
(less all Notes converted to Common Stock) on the day of a Public Information Failure and on every thirtieth day (pro-rated for
periods totaling less than thirty days) thereafter until the earlier of (i) the date such Public Information Failure is cured and
(ii) such time that such public information is no longer required pursuant to Rule 144. The payments to which a holder shall be
entitled pursuant to this Section 4(l) are referred to herein as “Public Information Failure Payments.”
Notwithstanding the foregoing, in no event shall the Public Information Failure Payments exceed 10% of the aggregate Purchase Price
of such holder’s outstanding Notes. Public Information Failure Payments shall be paid on the earlier of (I) the last day
of the calendar month during which such Public Information Failure Payments are incurred and (II) the third Business Day after
the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public
Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1%
per month (prorated for partial months) until paid in full.

 

(m)          
Trading Activities. Neither the Buyers nor any of their respective affiliates has an
open short position (or other hedging or similar transactions) in the Common Stock and the Buyers agree that they shall not, and
that it will cause their respective affiliates not to, engage in any short sales of or hedging transactions with respect to the
Common Stock.

 

(n)            
Taxes. The Company will pay, and save and hold the Buyers harmless from any and all
liabilities (including interest and penalties) with respect to, or resulting from any delay or failure in paying, stamp and other
taxes (other than income taxes), if any, which may be payable or determined to be payable on the execution and delivery or acquisition
of the Notes, Warrants, In-Kind Payment Shares or Warrant Shares.

 

(o)            
Deleted. 

 

(p)            
Books and Records. The Company will keep proper books of record and account, in which
full and correct entries shall be made of all financial transactions and the assets and business of the Company and its Subsidiaries
in accordance with GAAP.

 

(q)            
Notice of Disqualification Events. The Company will notify the Buyers in writing, prior
to the First or Second Closing of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that
would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.

 

(r)             
New Debt. For a period of one year from the Execution Date, neither the Company nor
any Subsidiary shall enter into any agreement creating indebtedness for the Company or any Subsidiary, including but not limited
to entering into (i) any mortgage, credit agreement or other facility, indenture agreement, factoring agreement or other instrument,
under which there may be issued, or by which there may be secured or evidenced, any indebtedness for borrowed money or money due
that involves, either individually or in aggregate with other such agreements, obligations greater than $100,000.00, and (ii) any
equipment lease, agreement evidencing purchase money security interests, or other similar transaction in the ordinary course of
business that involves, either individually or in aggregate with other such agreements, obligations greater than $250,000.00, in
either case without the prior written consent of the Required Holders. 

 

(s)            
Distributions. While the Notes remain outstanding, the Company shall not make any distributions
of cash or property on equity, without the prior written consent of the Required Holders. Notwithstanding the foregoing, the Company
may effect stock dividends and stock splits as provided by law.

 

(t)             
DTC Eligibility. For so long as any Securities are outstanding, the Company will employ
as the transfer agent for the Common Stock a participant in the Depository Trust Company Automated Securities Transfer Program
and cause the Common Stock to be transferable pursuant to such program.

 

 

 

    	 	19	 

     

    

 

(u)            
Closing Documents. On or prior to thirty (30) calendar days after the First Closing,
the Company agrees to deliver, or cause to be delivered, to each Buyer and K&L Gates, LLP a complete closing set of the executed
Transaction Documents, Securities and any other documents required to be delivered to any party pursuant to Section 7 hereof
or otherwise.

 

(v)            
Co-Operation. If, on behalf of a Buyer, a broker-dealer requests the Company to provide
information concerning Securities of the Company held by a Holder, the Company will use commercially reasonable efforts to provide
the requested information to the extent it has the information and the request seeks information which is not privileged.

 

(w)          
Lock-Box. In the event that the Company defaults under any of the Notes or Warrants,
the Company shall enter into a lock-box agreement with the Buyers whereby (i) each month, the Company shall wire a minimum of $97,222.00
of its gross revenues following the First Closing and $194,444.00 of its revenues following the Second Closing, on a monthly basis,
into a bank account designated by Sea Otter for Sea Otter to direct the satisfaction of the Company’s obligations under the
Notes as agent for and on behalf of all Buyers, pro rata, and (ii) such agreement shall contain such other terms expressly set
forth in the term sheet that preceded and such other terms as customary in agreements of that kind.

 

(x)            
No Transfer to Non-Buyers. Each of the Buyers agrees that, as long as any of the Notes
remain outstanding, no Buyer shall transfer, assign, or otherwise dispose of its Notes, Warrants, or any rights under this Agreement,
to any third-party that is not one of the Buyers listed on the Schedule of Buyers. It is agreed that if there is a breach
by any Buyer of the foregoing sentence, the other Buyers cannot be adequately or reasonably compensated by money damages. Accordingly,
in the event of a breach by a Buyer of this Section 4(x), the Buyers agree that such a breach would cause irreparable injury
to the other Buyers and the Company, and that if the Company or the other Buyers shall bring legal proceedings against the violating
Buyer to enforce such restrictive covenant, the Company and plaintiff Buyers shall be entitled to seek all available civil remedies,
at law or in equity, including, without limitation, an order of specific performance, an injunction without posting a bond, monetary
damages, attorneys’ fees, and costs.

 

(y)            
Reservation of Shares. On or before November 30, 2017, the Company shall have filed
a Schedule 14C with the SEC calling for a special meeting of its stockholders to authorize additional shares. Upon such vote, the
Company shall take all actions necessary to at all times have authorized, and reserved for the purpose of issuance, no less than
300% of the maximum number of shares of Common Stock issuable (i) upon conversion of the maximum amount of Notes (assuming for
purposes hereof, that the Notes are convertible at the Conversion Price and without taking into account any limitations on the
conversion of the Notes set forth in therin) and (ii) upon exercise of the Warrants (without taking into account any limitations
on the exercise of the Warrants set forth in the Warrants), in each case, determined as if issued as of the trading day immediately
preceding the applicable date of determination (the “Required Reserved Amount”). If at any time the number of
shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserved Amount, the Company
will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation,
calling an additional special meeting of stockholders to authorize additional shares to meet the Company’s obligations under
this covenant, in the case of an insufficient number of authorized shares, obtain stockholder approval of an increase in such authorized
number of shares, and voting any treasury shares of the Company in favor of an increase in the authorized shares of the Company
to ensure that the number of authorized shares is sufficient to meet the Required Reserved Amount. In connection with any such
vote, each Buyer hereby agrees that it shall, if requested by the Company, vote all shares of capital stock held by such Buyer
in favor of any such increase in the authorized number of shares. 

 

(z)            
DTC Eligibility. On or prior to November 30, 2017, the Company, through its transfer
agent, will be a participant in the DTC Fast Automated Securities Transfer (FAST) Program and the Common Stock will be eligible
to be transferred electronically to third parties via the DTC Fast Automated Securities Transfer (FAST) Program.

 

5.              
REGISTER.

 

The Company shall
maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice to each
holder of Securities), a register for the Notes in which the Company shall record the name and address of the Person in whose name
the Notes have been issued (including the name and address of each transferee), the amount of Notes held by such Person and the
number of In-Kind Payment Shares issuable upon conversion of the Notes held by such Person. The Company shall keep the register
open and available at all times during business hours for inspection of any Buyer or its legal representatives.

 

 

 

    	 	20	 

     

    

 

6.              
CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.

 

The obligation of the
Company hereunder to issue and sell the Notes and the related Warrants to each Buyer at the First and the Second Closing, if applicable
is subject to the satisfaction, at or before the Closing, of each of the following conditions, provided that these conditions are
for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion by providing each Buyer
with prior written notice thereof:

 

(i)             
Such Buyer shall have executed each of the Transaction Documents to which it is a party and
delivered the same to the Company.

 

(ii)           
Such Buyer shall have delivered to the Company the Purchase Price (less, in the case of any
Buyer, the amount withheld by such Buyer pursuant to Section 4(f)) for the Notes being purchased by such Buyer at the Closing
by wire transfer of immediately available funds pursuant to the wire instructions provided by the Company.

 

(iii)         
The representations and warranties of such Buyer shall be true and correct as of the date
when made and as of the First and the Second Closing, if applicable, as though made at that time (except for representations and
warranties that speak as of a specific date, which shall be true and correct as of such specified date), and such Buyer shall have
performed, satisfied and complied with the covenants, agreements and conditions required by this Agreement to be performed, satisfied
or complied with by such Buyer at or prior to the First and the Second Closing, if applicable.

 

(iv)          
Prior to the Second Closing Date, each Buyer listed on the Schedule of Buyers shall
have delivered its Purchase Price to the Company and otherwise satisfied its obligations regarding the First Closing, and shall
have initiated payments via wire transfer regarding the Purchase Price payments required for the Second Closing.

 

7.              
CONDITIONS TO EACH BUYER’S OBLIGATION TO PURCHASE. 

 

The obligation of each
Buyer hereunder to purchase the Notes and the related Warrants at each Closing is subject to the satisfaction, at or before the
First Closing and the Second Closing, if applicable, of each of the following conditions, provided that these conditions are for
each Buyer’s sole benefit and may be waived by such Buyer at any time in its sole discretion by providing the Company with
prior written notice thereof:

 

(i)             
The Company shall have duly executed and delivered to such Buyer each of the Transaction Documents
and the certificates representing the Notes and the Warrants (allocated in such numbers as such Buyer shall request in writing
at least two (2) Business Days prior to the First and the Second Closing, if applicable) being purchased by such Buyer at the Closing
pursuant to this Agreement.

 

(ii)           
The Company shall have delivered to such Buyer a certificate evidencing the formation and
good standing of the Company and each of its Subsidiaries in each such entity’s jurisdiction of formation issued by the Secretary
of State (or equivalent) of such jurisdiction of formation as of a date within ten (10) days before the First Closing.

 

(iii)         
The Company shall have delivered to such Buyer a certified copy of the Articles of Incorporation
as certified by the Secretary of State of the State of Nevada within ten (10) days of the First Closing.

 

(iv)          
The Company shall have delivered to such Buyer a certificate, executed by the Secretary of
the Company and dated as of each Closing Date, as to (i) the resolutions consistent with Section 3(b) as adopted by the
Company’s board of directors in a form reasonably acceptable to such Buyer, (ii) the Articles of Incorporation, (iii) the
Bylaws, each as in effect at the First Closing, and (iv) an incumbency certificate signed by an officer or officers of the Company
certifying the signature and office of each officer executing this Agreement or any other Transaction Documents. 

 

(v)            
The representations and warranties of the Company shall be true and correct as of the date
when made and as of the First and the Second Closing Date, if applicable as though made at that time (except for representations
and warranties that speak as of a specific date, which shall be true and correct as of such specified date) and the Company shall
have performed, satisfied and complied in all respects with the covenants, agreements and conditions required by the Transaction
Documents to be performed, satisfied or complied with by the Company at or prior to the First and the Second Closing, if applicable.
Such Buyer shall have received a certificate, executed by the Chief Executive Officer of the Company, dated as of the First Closing
and the Second Closing, if applicable, to the foregoing effect and as to such other matters as may be reasonably requested by such
Buyer.

 

 

 

    	 	21	 

     

    

 

(vi)          
The Company shall have obtained all governmental, regulatory or third party consents and approvals,
if any, necessary for the sale of the Securities.

 

(vii)        
The Notes in the form attached hereto as Exhibit A shall have been delivered and shall
be in full force and effect, enforceable against the Company in accordance with their terms and shall not have been amended.

 

(viii)      
The Warrants in the form attached hereto as Exhibit B shall have been delivered and
shall be in full force and effect, enforceable against the Company in accordance with their terms and shall not have been amended.

 

(ix)          
All of the Commitment Shares shall have been delivered to the Buyers at the First Closing.

 

(x)            
Prior to each Closing, the Company and its transfer agent shall have executed irrevocable
instructions regarding the issuance of shares of Common Stock upon the in-kind payment/exercise of the Notes and Warrants, in a
form acceptable to Sea Otter.

 

(xi)          
The Company shall have delivered to such Buyer such other documents relating to the transactions
contemplated by this Agreement as such Buyer or its counsel may reasonably request.

 

(xii)        
Prior to the Second Closing Date, the Company shall have executed definitive documents, sufficient,
in Sea Otter’s sole determination, to effect the closing of the Contemplated Transaction. 

 

8.              
TERMINATION.

 

In the event that
(i) the First Closing shall not have occurred with respect to a Buyer on or before ten (10) Business Days from the Execution Date
due to the Company’s or such Buyer’s failure to satisfy the conditions set forth in Sections 6 and 7
above (and the nonbreaching party’s failure to waive such unsatisfied condition(s)), or (ii) the Second Closing shall not
have occurred with respect to a Buyer on or before ninety (90) days from the Execution Date due to the Company’s or such
Buyer’s failure to satisfy the conditions set forth in Sections 6 and 7 above (and the nonbreaching party’s
failure to waive such unsatisfied condition(s)), then in either case, the nonbreaching parties shall have the option to terminate
this Agreement with respect to such breaching party at the close of business on such date by delivering a written notice to that
effect to each other party to this Agreement and without liability of any party to any other party; provided, however,
that if this Agreement is terminated pursuant to this Section 8, the Company shall remain obligated to reimburse Sea Otter
for the expenses described in Section 4(f) above.

 

9.              
MISCELLANEOUS.

 

(a)            
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address
for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

(b)            
Counterparts. This Agreement may be executed in two or more identical counterparts,
all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party; provided that an e-mail signature shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original, not an e-mail signature.

 

(c)            
Headings. The headings of this Agreement are for convenience of reference and shall
not form part of, or affect the interpretation of, this Agreement.

 

 

 

    	 	22	 

     

    

 

(d)            
Severability. If any provision of this Agreement is prohibited by law or otherwise
determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited,
invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the
invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so
long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as
to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not
substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits
that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the
prohibited, invalid or unenforceable provision(s).

 

(e)            
Entire Agreement; Amendments. This Agreement and the other Transaction Documents supersede
all other prior oral or written agreements between the Buyers, the Company, their affiliates and Persons acting on their behalf
with respect to the matters discussed herein, and this Agreement, the other Transaction Documents and the instruments referenced
herein and therein contain the entire understanding of the parties with respect to the matters covered herein and therein and,
except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation, warranty, covenant
or undertaking with respect to such matters. Provisions of this Agreement may be amended and the observance thereof may be waived
(either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the
Company and either (i) the holders of at least a majority of the Notes outstanding as of the applicable date of determination which
must include Sea Otter as long as Sea Otter (or any of its Affiliates) owns at least five percent (5%) of the Notes issued pursuant
to this Agreement, or (ii) Sea Otter as long as Sea Otter (or any of its Affiliates) owns at least five percent (5%) of the Notes
issued pursuant to this Agreement (the “Required Holders”); provided that any such amendment or waiver that
complies with the foregoing but that disproportionately, materially and adversely affects the rights and obligations of any Buyer
relative to the comparable rights and obligations of the other Buyers shall require the prior written consent of such adversely
affected Buyer. Any amendment or waiver effected in accordance with this Section 9(e) shall be binding upon each Buyer and
holder of Securities and the Company. No such amendment shall be effective to the extent that it applies to less than all of the
Buyers or holders of Securities. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of any of the Transaction Documents unless the same consideration (other than the reimbursement of legal fees)
also is offered to all of the parties to the Transaction Documents, holders of Notes or holders of Warrants, as the case may be.
The Company has not, directly or indirectly, made any agreements with any Buyers relating to the terms or conditions of the transactions
contemplated by the Transaction Documents except as set forth in the Transaction Documents. Without limiting the foregoing, the
Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has any other obligation
to provide any financing to the Company or otherwise.

 

(f)             
Notices. Any notices, consents, waivers or other communications required or permitted
to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when
delivered personally; (ii) upon receipt, when sent by e-mail; or (iii) one (1) Business Day after deposit with an overnight courier
service, in each case properly addressed to the party to receive the same. The addresses and email addresses for such communications
shall be:

 

If to the Company:

 

Probility Media Corp.

1517 San Jacinto Street

Houston, TX 77002

Attention: Mr. Evan M. Levine, Chairman &
CEO

E-mail: evan@probilitymedia.com

 

 

With a copy (for informational
purposes only) to:

 

Olshan Frome Wolosky, LLP

1325 Avenue of the Americas, 15th Floor

New York, New York 10019

Attn: Spencer G. Feldman,
Esq.

E-mail: sfeldman@olshanlaw.com

 

 

 

    	 	23	 

     

    

 

 

If to a Buyer, to its address and email
address set forth on the Schedule of Buyers, with copies to such Buyer’s representatives as set forth on the Schedule
of Buyers,

 

With a copy (for informational
purposes only) to:

 

K&L Gates LLP

200 S. Biscayne Boulevard,
Suite 3900

Miami, FL 33131

Telephone: 305.539.3300

E-mail:     john.owens@klgates.com

Attention: John D. Owens, III, Esq.

 

or to such other address and/or email address
and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party five
(5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice,
consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s email containing the
time, date, recipient e-mail and an image of the first page of such transmission or (C) provided by an overnight courier service
shall be rebuttable evidence of personal service, receipt by e-mail or receipt from an overnight courier service in accordance
with clause (i), (ii) or (iii) above, respectively.

 

(g)            
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit
of the parties and their respective successors and assigns, including any purchasers of the Notes or the Warrants. The Company
shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Required Holders,
except by operation of law. A Buyer may assign some or all of its rights hereunder without the consent of the Company, in which
event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.

 

(h)            
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person, except that each Indemnitee shall have the right to enforce the obligations of the Company with respect to
Section 9(k).

 

(i)             
Survival. Unless this Agreement is terminated under Section 8, the representations,
warranties, agreements and covenants hereunder shall survive the Closing and the delivery, conversion and/or exercise of the Securities,
as applicable. Each Buyer shall be responsible only for its own representations, warranties, agreements and covenants hereunder.

 

(j)             
Further Assurances. Each party shall do and perform, or cause to be done and performed,
all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents,
as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the
consummation of the transactions contemplated hereby.

 

(k)            
Indemnification. 

 

(i)             
In consideration of each Buyer’s execution and delivery of the Transaction Documents
and acquiring the Securities thereunder and in addition to all of the Company’s other obligations under the Transaction Documents,
the Company shall defend, protect, indemnify and hold harmless each Buyer and each other holder of the Securities and all of their
stockholders, partners, members, officers, directors, employees and direct or indirect investors and any of the foregoing Persons’
agents or other representatives (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) (collectively, the “Indemnitees”) from and against any and all actions, causes of action,
suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective of whether
any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable attorneys’
fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising
out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by the Company in the Transaction
Documents or any other certificate, instrument or document contemplated hereby or thereby, (b) any breach of any covenant, agreement
or obligation of the Company contained in the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby or (c) any cause of action, suit or claim brought or made against such Indemnitee by a third party (including
for these purposes a derivative action brought on behalf of the Company) and arising out of or resulting from (i) the execution,
delivery, performance or enforcement of the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby, (ii) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds
of the issuance of the Securities, (iii) any disclosure made by such Buyer pursuant to Section 4(h), or (iv) the status
of such Buyer or holder of the Securities as an investor in the Company pursuant to the transactions contemplated by the Transaction
Documents. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make
the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable
law. 

 

 

 

    	 	24	 

     

    

 

(ii)           
Promptly after receipt by an Indemnitee under this Section 9(k) of notice of the commencement
of any action or proceeding (including any governmental action or proceeding) involving an Indemnified Liability, such Indemnitee
shall, if a claim for indemnification in respect thereof is to be made against any indemnifying party under this Section 9(k),
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right
to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed,
to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnitee; provided,
however, that an Indemnitee shall have the right to retain its own counsel with the fees and expenses of not more than one counsel
for such Indemnitee to be paid by the indemnifying party, if, in the reasonable opinion of counsel selected to defend the Indemnitee,
the representation by such counsel of the Indemnitee and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnitee and any other party represented by such counsel in such proceeding. Legal counsel referred
to in the immediately preceding sentence shall be selected by the Investors holding at least a majority of the Purchased Shares.
The Indemnitee shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such action
or Indemnified Liabilities by the indemnifying party and shall furnish to the indemnifying party all information reasonably available
to the Indemnitee that relates to such action or Indemnified Liabilities. The indemnifying party shall keep the Indemnitee fully
apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party
shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent, provided, however,
that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without
the prior written consent of the Indemnitee, which consent shall not be unreasonably withheld conditioned or delayed, consent to
entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such Indemnitee of a release from all liability in respect to such Indemnified Liabilities
or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of
the Indemnitee with respect to all third parties, firms or corporations relating to the matter for which indemnification has been
made. No Indemnitee shall enter into any settlement of any action or proceeding subject to this Section 9(k) without the prior
written consent of the indemnifying party. The failure to deliver written notice to the indemnifying party within a reasonable
time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnitee under
this Section 9(k), except to the extent that the indemnifying party is prejudiced in its ability to defend such action.

 

(iii)         
The indemnification required by this Section 9(k) shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or Indemnified Liabilities
are incurred.

 

(iv)          
The indemnity agreements contained herein shall be in addition to (x) any cause of action
or similar right of the Indemnitee against the indemnifying party or others, and (y) any liabilities the indemnifying party may
be subject to pursuant to the law.

 

(l)             
No Strict Construction. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any
party.

 

(m)          
Remedies. Each Buyer and each holder of the Securities shall have all rights and remedies
set forth in the Transaction Documents and all rights and remedies which such holders have been granted at any time under any other
agreement or contract and all of the rights which such holders have under any law. Any Person having any rights under any provision
of this Agreement shall be entitled to enforce such rights specifically to recover damages by reason of any breach of any provision
of this Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes that in the event that it
fails to perform, observe, or discharge any or all of its obligations under the Transaction Documents, any remedy at law may prove
to be inadequate relief to the Buyers. The Company therefore agrees that the Buyers shall be entitled to seek temporary and permanent
injunctive relief in any such case without the necessity of proving actual damages.

 

(n)            
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained
in (and without limiting any similar provisions of) the Transaction Documents, whenever any Buyer exercises a right, election,
demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods
therein provided, then such Buyer may rescind or withdraw, in its sole discretion from time to time upon written notice to the
Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights.

 

 

 

    	 	25	 

     

    

 

(o)            
Payment Set Aside. To the extent that the Company makes a payment or payments to the
Buyers hereunder or pursuant to any of the other Transaction Documents or the Buyers enforce or exercise their rights hereunder
or thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation,
any bankruptcy law, foreign, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if
such payment had not been made or such enforcement or setoff had not occurred.

 

(p)            
Reproduction of Documents. This Agreement and all documents relating thereto, including,
without limitation, (a) consents, waivers and modifications which may hereafter be executed, (b) documents received by the Buyers
on the First and the Second Closing, if applicable (except for certificates evidencing the Notes themselves), and (c) financial
statements, certificates and other information previously or hereafter furnished to the Buyers, may be reproduced by any Buyer
by any photographic, photostatic, microfilm, micro-card, miniature photographic or other similar process and any Buyer may destroy
any original document so reproduced. All parties hereto agree and stipulate that any such reproduction shall be admissible in evidence
as the original itself in any judicial or administrative proceeding (whether or not the original is in existence and whether or
not such reproduction was made by a Buyer in the regular course of business) and that any enlargement, facsimile or further reproduction
of such reproduction shall likewise be admissible in evidence.

 

(q)            
Independent Nature of Buyers’ Obligations and Rights. The obligations of each
Buyer under any Transaction Document are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible
in any way for the performance of the obligations of any other Buyer under any Transaction Document. Nothing contained herein or
in any other Transaction Document, and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the
Buyers as, and the Company acknowledges that the Buyers do not so constitute, a partnership, an association, a joint venture or
any other kind of entity, or create a presumption that the Buyers are in any way acting in concert or as a group, and the Company
shall not assert any such claim with respect to such obligations or the transactions contemplated by the Transaction Documents
and the Company acknowledges that the Buyers are not acting in concert or as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents. The Company acknowledges and each Buyer confirms that it has independently participated
in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be
entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement
or out of any other Transaction Documents, and it shall not be necessary for any other Buyer to be joined as an additional party
in any proceeding for such purpose.

 

 

** Signature Page Follows **

 

 

 

 

 

 

 

 

 

 

    	 	26	 

     

    

 

IN WITNESS WHEREOF,
each Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed
as of the Execution Date.

 

	 	
        COMPANY:

         

	 	
        PROBILITY
        MEDIA CORPoration

         

         

        By: /s/ Steven M. Plumb

        Name: Steven M. Plumb

        Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	27	 

     

    

 

IN WITNESS WHEREOF,
each Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed
as of the Execution Date.

 

 

	 	
        BUYERS:

         

	 	
        SBI INVESTMENTS LLC, 2014-1

         

         

         

        By: /s/ Peter Wisniewski

        Name: Peter Wisniewski

        Title: Manager

         

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	28	 

     

    

 

IN WITNESS WHEREOF,
each Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed
as of the Execution Date.

 

	 	BUYERS:

 

	 	By:	
        /s/ Thomas
Walsh

        Name: Thomas Walsh

        Title: General Partner

                  Cavalry Fund I, LP

         

        

	 	 	 
	 	By:	/s/ Stephanie Deutsch
	 	 	Name: Stephanie Deutsch
	 	 	Title:    Manager, JJBL, LLC
	 	 	 
	 	By:	
        /s/ David Clark

        Name: David Clark

        Title: Principal

Vista Capial Investements, LLC

	 	 	 
	 	By:	
        /s/ Felicia Preston

        Name: Felicia Preston

        Title: Director

        EMA Financial, LLC

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	29	 

     

    

 

SCHEDULE OF BUYERS

FIRST CLOSING

	(1)	(2)	(3)	(4)	(5)	(6)	(7)
	Buyer
	Address
        and E-mail
	Principal
        Amount of Notes
	Aggregate
        Number of Warrants
	Purchase
        Price
	Legal
        Representative’s

        Address and E-mail
	 

        Commitment
Shares

	 	 	 	 	 	 	 
	SBI
    INVESTMENTS LLC, 2014-1	107 Grand
        Street, 7th FL

        New York,
        NY 10013

        Attn: Jonathan
        Juchno

        E-mail:
        jjuchno@seaotterglobal.com
	$875,000	972,222	$750,000	K&L
        Gates, LLP

        200 S. Biscayne
        Blvd.

        Ste. 3900

        Miami, FL
        33131

        Attn: John
        D. Owens, III, Esq.

        E-mail:
        john.owens@klgates.com

         
	120,968
	JJBLSR,
    LLC	1517 San
        Jacinto Street

        Houston,
        Texas 77002

        Attn: Noah
        Davis

        E-mail:
        noah@probilitymedia.com
	$262,500	291,667	$225,000	Rob D. Cucher,
        Esq.

        315 S. Beverly
        Drive, Suite 310

        Beverly
        Hills, CA 90212

        E-mail:
        cucherlaw@msn.com
	36,290
	EMA
    Financial, LLC	40 Wall
        Street 17th Fl.

        New York,
        NY 10005

        Attn: Felicia
        Preson

        E-mail:
        fpreston@emafin.com
	$145,825	161,972	$125,000	Peter J.
        Weisman, P.C.

        513 West
        Mt. Pleasant Ave., Suite 208

        Livingston,
        New Jersey 07039

        Attn: Peter
        J. Weisman, Esq.

        Email: pweisman@pweisman.com
	20,153
	CAVALRY
    FUND I, LP	61 Kinderkamack
        Rd.

        Woodcliff
        Lake, NY 07677

        Attention:
        Thomas Walsh

        E-mail:
        thomas@cavalryfund.com
	$233,325	259,194	$200,000	K&L
        Gates, LLP

        200 S. Biscayne
        Blvd.

        Ste. 3900

        Miami, FL
        33131

        Attn: John
        D. Owens, III, Esq.

        E-mail:
        john.owens@klgates.com
	32,250
	Vista
    Capital Investments, LLC	120 Birmingham
        Drive, Suite 230

        Cardiff
        by the Sea, CA 92007

        Attn: David
        Clark

        E-mail:
        dclark@vci.us.com
	$116,675	129,694	$100,000	120 Birmingham
        Drive, Suite 230

        Cardiff
        by the Sea, CA 92007

        Attn: David
        Clark

        E-mail:
        dclark@vci.us.com
	16,137
	 	 	 	 	 	 	 

 

 

 

    	 		 

     

    

 

SECOND CLOSING

 

	 	 	 	 	 	 	 	 
	SBI
    INVESTMENTS LLC, 2014-1	107 Grand
        Street, 7th FL

        New York,
        NY 10013

        Attn: Jonathan
        Juchno

        E-mail:
        jjuchno@seaotterglobal.com
	[      ]	[      ]	$[      ]	K&L
        Gates, LLP

        200 S. Biscayne
        Blvd.

        Ste. 3900

        Miami, FL
        33131

        Attn: John
        D. Owens, III, Esq.

        E-mail:
        john.owens@klgates.com

         
	 
	JJBLSR,
    LLC	1517 San
        Jacinto Street

        Houston,
        Texas 77002

        Attn: Noah
        Davis

        E-mail:
        noah@probilitymedia.com
	[      ]	[      ]	$[      ]	Rob D. Cucher,
        Esq.

        315 S. Beverly
        Drive, Suite 310

        Beverly
        Hills, CA 90212

        E-mail:
        cucherlaw@msn.com
	 	 
	EMA
    Financial, LLC	40 Wall
        Street 17th Fl.

        New York,
        NY 10005

        Attn: Felicia
        Preson

        E-mail:
        fpreston@emafin.com
	 	 	 	Peter J.
        Weisman, P.C.

        513 West
        Mt. Pleasant Ave., Suite 208

        Livingston,
        New Jersey 07039

        Attn: Peter
        J. Weisman, Esq.

        Email: pweisman@pweisman.com
	 	 
	CAVALRY
    FUND I, LP	61 Kinderkamack
        Rd.

        Woodcliff
        Lake, NY 07677

        Attention:
        Thomas Walsh

        E-mail:
        thomas@calvaryfund.com
	 	 	 	K&L
        Gates, LLP

        200 S. Biscayne
        Blvd.

        Ste. 3900

        Miami, FL
        33131

        Attn: John
        D. Owens, III, Esq.

        E-mail:
        john.owens@klgates.com
	 	 
	Vista
    Capital Investments, LLC	120 Birmingham
        Drive, Suite 230

        Cardiff
        by the Sea, CA 92007

        Attn: David
        Clark

        E-mail:
        dclark@vci.us.com
	 	 	 	120 Birmingham
        Drive, Suite 230

        Cardiff
        by the Sea, CA 92007

        Attn: David
        Clark

        E-mail:
        dclark@vci.us.com
	 	 
	 	 	 	 	 	 	 	 

 

 

 

 

 

    	 	 	 

     

    

 

 

EXHIBITS

 

 

Exhibit A          Form
of Promissory Note

Exhibit B          Form
of Warrant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]